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ABSTRACT 
 
Increased demand for animal disease surveillance information has led to the 
development and refinement of methodologies for qualitative and quantitative 
surveillance system evaluations to maximize efficiency and efficaciousness. The 
impetus for this surveillance evaluation project was chronic wasting disease 
(CWD) and the objectives were to apply both qualitative and quantitative 
methodologies to examine the components of CWD surveillance in 
Saskatchewan.  
 
A retrospective review of deer pathology and hunter-harvest submissions in 
Saskatchewan was conducted through the Canadian Cooperative Wildlife Health 
Centre. Qualitative evaluation methods outlined by Klauke et al (1988) were used 
and included key stakeholder interviews. A quantitative evaluation, with specific 
focus on disease detection, was conducted to examine system sensitivity, 
confidence of disease freedom and to compare system components using 
methods described by Martin et al (2007). The analysis was conducted using a 
scenario tree and Monte Carlo simulation.  
 
Sampling rates of dead and clinically ill deer were low with a high degree of 
variability by season, year, location and nature of submissions. Ultimately, 
variability of submission patterns likely affected when and where diseases were 
detected.  Poor data quality reduced the amount of available data for analysis but 
quality dramatically improved over time.  
The surveillance evaluation demonstrated that the current surveillance system 
places more emphasis on monitoring trends in CWD-positive areas, at the 
expense of early detection. This is explained mostly by the coupling of disease 
control efforts and surveillance, in that harvests are heavily focused in CWD-
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positive areas. The system is not sufficient to detect disease in new areas where 
the disease prevalence is low, primarily due to low submission rates.  
The quantitative evaluation found that overall sensitivity of the surveillance 
system and confidence of disease freedom was highly dependent on detection 
prevalence and the ongoing risk of disease introduction. Surveillance in the 
eastern part of Saskatchewan was not adequate from 1997-2006 to detect CWD 
at 0.5-1% prevalence. However, if risk of CWD introduction over this time period 
was assumed to be low, it can be concluded that the prevalence in this region 
was not 5% or higher.  
A detection goal of 0.5-1% prevalence is an ambitious surveillance goal, 
especially in areas where the risk of disease introduction is high. The use of 
more targeted surveillance strategies should be further explored to help better 
meet surveillance these surveillance objectives.  
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1. INTRODUCTION 
The demand for animal disease surveillance information has increased in recent 
years with the emergence and re-emergence of new and old infectious diseases 
affecting both humans and animals alike. Diseases such as influenza (avian and 
swine variants) and West Nile virus have both necessitated and enabled animal 
and human health jurisdictions to work together to meet these new challenges.  
Surveillance systems are at the core of animal and public health management 
policy decisions and this increased demand has contributed to the development 
and refinement of methodologies for qualitative and quantitative surveillance 
system evaluation. Surveillance evaluations, regardless of methodology are 
currently under-utilized and more regular, systematic evaluations would help to 
improve efficiency, efficacy and appropriate resource allocation. The impetus for 
this surveillance evaluation is chronic wasting disease, which has continued to 
spread throughout Saskatchewan in recent years despite aggressive disease 
control efforts and which poses a unique and increasing surveillance challenge.  
 
In Saskatchewan, CWD surveillance in wild cervids is used to identify infected 
populations, monitor trends, and measure the effectiveness of disease 
management efforts. The program primarily relies on samples from healthy deer 
that are submitted by hunters; there is also limited testing of compromised, 
clinically diseased deer (diseased, dying or dead) through the Canadian 
Cooperative Wildlife Health Centre’s wildlife diagnostic pathology service. Among 
these, is a subset of deer with clinical signs consistent with CWD. It is intuitive 
that targeting surveillance efforts toward CWD ‘suspects’ (poor body condition 
with neurologic dysfunction) would be an efficient way to detect disease; these 
animals have a greater probability of being infected. However it is difficult to 
quantify the benefits of targeted testing and to interpret negative findings using 
this strategy.  
 
Surveillance evaluations can be used to help further describe the value of 
targeted testing and to assist with interpreting negative findings. Similar to the 
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sensitivity of a diagnostic test which estimates the confidence we may have in 
the test results, the sensitivity of a surveillance system can be calculated to 
quantify the probability that the disease will be detected by the surveillance 
system above a certain pre-set threshold. From this, we can describe negative 
surveillance results in terms of disease freedom; we can also compare 
surveillance systems in order to determine which system will work best to meet 
objectives. 
  
1.1 Objectives 
This project has the following objectives: 1) To retrospectively review white-tailed 
and mule deer diagnostic pathology submissions from 1966-2006 in 
Saskatchewan in order to characterize this passive surveillance system and 
describe submission patterns, including demographic, temporal or spatial trends  
2) To describe the current CWD surveillance system 3) to conduct a qualitative 
surveillance evaluation and examine the use and value of diagnostic pathology 
submissions in the surveillance of chronic wasting disease as compared to 
hunter-harvested sampling techniques, 4) To model CWD surveillance systems 
using a scenario tree and 5) To conduct a quantitative evaluation using 
stochastic simulation modeling to calculate the sensitivity of the CWD 
surveillance system and quantify the value of target testing.  
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2. LITERATURE REVIEW                      
 
2.1 CHRONIC WASTING DISEASE 
2.1.1 Agent 
Chronic wasting disease (CWD) is a fatal, infectious, neurodegenerative prion 
disease (transmissible spongiform encephalopathy; TSE) that affects both free-
ranging and captive cervid species in North America. Prions are devoid of nucleic 
acid and are composed of modified protein which causes normal cellular 
glycoprotein (PrPC) to become abnormally refolded (PrPCWD) (Prusiner, 1998).  
 
2.1.2. Susceptible species  
Species known to be naturally susceptible to CWD are mule deer (Odocoileus 
hemionus), white-tailed deer (Odocoileus virginianus), Rocky Mountain elk 
(Cervus elaphus) and moose (Alces alces) (Williams and Young, 1980; Williams 
and Young, 1982; Williams and Young, 1992; Kreeger et al., 2006). Black-tailed 
deer (Odocoileus hemionus columbianus), a subspecies of mule deer are also 
susceptible to CWD (Williams, 1980). Although there are many similarities 
between CWD outbreaks in deer and elk, there are some differences. Prevalence 
in wild elk is much lower than in wild deer. This could be partly attributed to the 
distribution and quantity of prion in different tissues throughout the body. PrPCWD 
levels have been found to be lower in lymphoid tissues of elk compared to deer, 
which suggest that infected deer may be more likely than elk to transmit the 
disease (Race et al., 2007).  
 
It is considered likely that other subspecies of white-tailed deer, mule deer, and 
elk would also be susceptible if sufficiently exposed (Williams, 2005). 
Susceptibility of caribou (Rangifer tarandus) to CWD remains unknown, but some 
level of susceptibility seems likely based on similarities between the normal cell 
prion proteins of caribou and mule deer (Bollinger et al., 2004; Happ et al., 2007) 
This is of great concern as caribou typically have large herd sizes, seasonal 
aggregations and range fidelity; therefore there is a high potential for CWD to 
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spread in northern Canada, if it were to be introduced in this species (Bollinger et 
al., 2004). CWD has not been successfully transmitted by oral inoculation to 
species outside of the cervid family, suggesting a strong species barrier 
(Sigurdson, 2008).  
 
Cattle appear to be highly resistant to CWD, and cattle did not become infected 
after years of co-grazing with CWD-infected mule deer, grazing in CWD-infected 
areas, or following direct oral exposure of mule deer CWD prions (Gould et. al, 
2003; Williams, 2005; Sigurdson, 2008).  
 
Although there is no definitive evidence, sheep are more likely to be susceptible 
to CWD. They have been shown to be susceptible via intracerebral inoculation 
(Hamir et al., 2006). The susceptibility of sheep to CWD by oral exposure has not 
been studied (Williams, 2005).  
 
2.1.3 Transmission 
CWD is transmitted horizontally through direct contact with infected animals and 
indirectly by exposure to environments contaminated with PrPCWD containing 
secretions (saliva), tissues or decomposed carcasses (Sigurdson, 2008; Miller 
and WIlliams, 2003; Miller et. al, 2004; Mathiason et al., 2006). The role of 
maternal transmission appears to be minimal (Miller and Williams, 2003), 
although elk calves born to positive dams are at greater risk of CWD, likely due 
to increased lateral transmission via close association (Argue et al., 2007). A 
recent study examining whether infectious PrPCWD in body fluids and excreta 
were capable of inducing CWD showed successful transmission to white-tailed 
deer fawns via saliva (50ml X 3 inoculations) given orally, and blood (250mL X 1 
inoculation) given intravenously and intraperitoneally. Repeated exposures of 
urine (50mL) and feces (50g) given orally did not produce detectable levels of 
PrPCWD, however small sample size, elective preclinical termination, and genetic 
variation in individual susceptibility may have resulted in type II error (Mathiason 
et al., 2006).  
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The point following exposure at which an animal become infectious is not known, 
however it is believed that shedding of PrPCWD begins some time around the 
onset of clinical signs and is progressive throughout the course of the disease 
(Williams and Miller, 2002; Miller et al., 2000).  The average survival time of an 
infectious clinically affected deer is estimated to be about 1.05yr (Miller et al., 
2000).   
 
The main factors which drive the geographic expansion of the disease are not 
currently known, however it has been speculated that juvenile dispersal 
movement and disease spread among matriarchal social groups may play a role 
(Joly et al., 2006). 
 
2.1.4 Pathophysiology 
Cervids are thought to become infected via the oral route. PrPCWD is first 
identified in the tonsils and gut-associated lymphoid tissues (Williams, 2005). 
Sigurdson et al. (1999) found PrPCWD accumulation in tonsils of mule deer as 
early as 78 days post-inoculation with CWD-positive brain material. PrPCWD 
moves to the central nervous system at the vagal nucleus and thoracic spinal 
cord. This is followed by progressive involvement in the central and peripheral 
nervous tissue. Once the animal is terminally ill, a wide variety of tissues may be 
involved, including other lymphoid tissue, the endocrine system, spleen, heart 
(Fox et al., 2006; Sigurdson et. al, 2001) and skeletal muscle (Angers et. al., 
2006).  
 
Accumulation of the abnormal prion protein in the nervous tissue leads to 
destruction of normal nervous tissue, and results in the clinical signs observed. In 
deer, the incubation period is seldom less than 18 months (Williams and Young, 
1993; Williams, 2005). 
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2.1.5 Clinical Signs  
Clinical signs associated with CWD in wild cervids have not been well described. 
Clinical signs, as observed in captive animals, involve a progressive loss of body 
condition and neurologic signs. Behavioral changes, such as periods of lack of 
awareness, fixed stare, altered flight distances (increased or decreased), altered 
stance with lowered head, repetitive walking and hyperexcitability when handled 
may be noted (Williams, 2005).  Other signs that may be observed include 
odontoprisis, excessive salivation due to difficulty swallowing, esophageal 
dilation and regurgitation causing aspiration pneumonia, polyuria/polydipsia and 
retention of winter hair coat (Williams, 2005; Argue et al., 2007). Deer with 
subclinical or early clinical infection are thought to be more susceptible to sudden 
death after handling than unaffected deer (Williams, 2005). Duration of clinical 
disease varies, however captive animals will typically show clinical signs for 
weeks to months. It is presumed that the duration may be somewhat shorter in 
free-ranging animals due to increased resource competition, and predator 
pressure (Williams, 2005). Those animals in clinical stages of infection are 
thought to be at increased risk for motor vehicle collisions (Krumm et al., 2005), 
hunter harvest (Conner et al. 2000), or being killed by predators (Williams, 2005). 
 
Once an animal is infected, the disease is invariably fatal and there are currently 
no available treatments. There is no vaccine to prevent the disease. 
 
2.1.6 Gross Pathology 
Gross lesions are typically non-specific. Body condition may vary depending on 
the stage of disease. Animals that are either subclinical or in early stages of 
clinical disease, may be in good body condition. As the disease progresses, body 
condition tends to decline, with animals in terminal stages typically emaciated. 
Other indicators on gross pathology may be aspiration pneumonia, dilute urine, 
and rumen contents may be watery, or have increased amounts of sand or gravel 
(Williams, 2005).  
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2.1.7 Histopathology 
Histologically, advanced disease is characterized by bilateral spongiform 
changes in the central nervous system with a noted lack of inflammatory 
response. Vacuolization occurs in the neuronal perikarya and neuronal 
processes (Williams and Young, 1980; Williams, 2005). Microscopic lesions are 
most obvious in the diencephalon, olfactory cortex, and nuclei of the medulla 
oblongata (dorsal vagal nucleus), however milder lesions are widespread in the 
brain and spinal cord (Spraker et al., 2002; Williams, 2005).  
 
2.1.8 Disease detection 
Abnormal prion protein (PrPCWD) can be detected by immunhistochemistry (IHC) 
in a number of tissues. In addition to demonstrating PrPCWD in nervous tissue, 
abnormal prion proteins are well distributed throughout the lymphoid tissue in 
deer and are readily detected by examining retropharyngeal lymph nodes and 
tonsillary tissue, often at very early stages of disease (Miller and Williams, 2002). 
A recent study (Hamir et. al, 2006) demonstrated positive PrPCWD by IHC in a 
preclinical white-tailed deer in the tonsils, spleen, various lymph nodes, Peyer’s 
patches and ectopic lymphoid follicles in the renal hilus. Another study using 
rodent models of scrapie showed PrPSC to be present in inflammatory lymphoid 
tissues in kidney, pancreas, and liver and showed that chronic inflammatory 
conditions may act as modifiers of prion transmission (Heinkenwalder et al., 
2005). Accumulation of PrPCWD in muscle tissue of infected animals is of concern 
if the animal is consumed. Angers et al. (2006) used skeletal muscle of CWD-
infected mule deer and transmitted the disease to transgenic mice expressing 
cervid prion protein. PrPCWD has been detected by IHC in cardiac myocytes of 
infected elk and white-tailed deer (Jewell et al., 2006) but the same study did not 
detect PrPCWD in diaphragm, triceps brachii, semitendinosus, latissiumus dorsi or 
tongue muscles.  Although some studies using laboratory animals (Thomzig et al, 
2003) have detected PrPSC in skeletal muscle and tongue, other studies (Hamir 
et al., 2004; Jewell et al., 2006) have contradicted those findings, leaving the 
question regarding skeletal muscle infectivity still inconclusive. A recent study 
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demonstrated PrPSC in skin of hamsters and sheep infected with scrapie; these 
findings suggest that in TSEs such as scrapie and CWD, virtually all tissues with 
nerve fibre innervations contain varying levels of prions during the clinical phase 
(Thomzig et al., 2007).   
 
2.1.9 Disease diagnosis  
Currently, testing in wild cervids in Saskatchewan involves using 
immunohistochemistry (IHC) techniques previously described (Spraker et al., 
2002). Available postmortem tissues from tonsil, retropharyngeal lymph node and 
obex are tested for presence of the abnormal prion protein. In deer, testing 
lymphoid tissue will detect 99% of cases by IHC (Spraker et al., 2002); however 
in elk both brain and lymphoid tissue must be tested as approximately 10-15% of 
cases will have detectable levels of PrPCWD in the brain, but not the lymphoid 
tissue (Spraker et al., 2004; Williams, 2005). A positive diagnosis is made when 
any one of the selected tissues mentioned above stain positive (Trent Bollinger, 
personal communication). Confirmatory testing is performed at the National 
Reference Laboratory for Transmissible Spongiform Encephalopathies, 
Canadian Food Infection Agency (Ottawa Laboratory, Fallowfield, Napean, ON, 
Canada) using immunohistochemistry.  
 
Rapid test enzyme-linked immunosorbent assays (ELISAs) are also used, and 
have good sensitivity when compared with IHC (Hibler et al., 2003). Current live 
animal testing techniques, such as tonsillary biopsies, are available but logistics 
and cost preclude routine use and these are primarily used in research settings 
(Wild et al., 2002). Other live animal testing techniques currently being developed 
with some promise include rectal mucosa biopsies (Spraker et al., 2009; Spraker 
et al., 2006).  
 
2.1.10 Implications of endemic CWD in wild cervid populations  
Once a population is affected, it appears as though a protracted epidemic occurs, 
resulting in a steady increase in prevalence over time and space (Miller et al., 
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2000). Long term population affects are unknown, however modeling done by 
Miller et al. (2000) suggests that ‘epidemics sustained over 30 to 50 yr could 
reduce affected populations dramatically’, and that epidemics would be ‘self-
limiting, driving the population to extinction’.  This has been shown in captive 
situations where more intensive transmission occurs under confinement 
(Williams and Young, 1992).  Because free-ranging populations occupy a larger 
geographic region, with more complex interactions, the ultimate outcome is 
unknown.  
 
In Saskatchewan, CWD appears to be currently restricted to four distinct 
geographic regions (Figure 1). Survey results conducted since 2000, suggest 
that the local prevalence is increasing in some areas, regardless of disease 
control actions taken (T. Bollinger, personal communication). 
 
In terms of impact on the population, the long-term effects of CWD may alter the 
genetic composition of herds affected. Species specific polymorphisms at the 
Prnp gene appear to affect susceptibility to CWD infection. It appears as though 
certain genetic lines are predisposed to shorter incubation periods of disease, 
while others experience a longer, more protracted course of disease. O’Rourke 
et al. (1999) was able to demonstrate that elk that were homozygous for 
methionine at codon 132 (132MM) were overrepresented among elk infected with 
CWD, when compared to elk heterozygous for methionine and leucine (132ML) 
or homozygous for leucine (132LL); experiments suggest that 132MM or 132ML 
elk develop clinical disease earlier (23-40 months) than elk with 132LL (59-64 
months) (Sigurdson, 2008). Other studies have demonstrated that mule deer 
heterozygous for serine/phenylalanine at codon 225 (225SF) appear to have 
prolonged incubation periods, when compared with homozygous (225SS) deer 
(Jewell, et al., 2005; Fox et al., 2006; Sigurdson, 2008). White-tailed deer have a 
polymorphism at codon 96, and deer that express 96SS had a lower risk of 
CWD, but were not resistant (Sigurdson, 2008). Although this area needs further 
research to better understand the impact of genetic composition and disease 
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dynamics, it is conceivable that the genetic structure of populations could change 
over time and the impacts of this change on biodiversity is unknown.  
 
There is a great economic cost associated with this disease through both disease 
surveillance management activities, and loss of hunting revenues. Management 
programs based on large herd reductions in affected areas may result in 
reduction of viewing opportunities and associated revenues (Bollinger et al., 
2004) and are not well received by the public. Many landowners are concerned 
that the herd reductions disrupt their livestock and are reluctant to allow hunter 
access.  Although initial observations in Canada and the USA indicate that the 
majority of hunters continue to hunt in areas even when CWD has been 
detected, there is concern that if CWD prevalence becomes high, public attitudes 
may change and human health concerns may reduce hunting activity (Bollinger 
et al., 2004). 
 
Chronic wasting disease has also had a large impact on the Canadian game-
farming industry. The discovery of chronic wasting disease in game-farmed 
populations in Canada led Korea to impose trade restrictions in December 2000 
(Kim et al., 2005), contributing to a decline in both demand and price of Canadian 
elk velvet antler product (Kahn et al., 2004). Current farming practices do not 
appear to prevent disease transmission ‘across the fence’, and therefore the 
status of surrounding wildlife populations ultimately impacts the international 
perceived risks associated with Canadian cervids and their products.  
 
There is currently no evidence to suggest that humans are susceptible to CWD 
(Anderson et al., 2007; Belay et al., 2001; Belay et al., 2003; Belay et al., 2004; 
Davis et al., 2003;  MaWhinney et al., 2006). However, as with Bovine 
Spongiform Encephalopathy (BSE), it is possible that humans are highly resistant 
to CWD infection and without extensive, prolonged exposure to high doses of 
prions, as occurred in the United Kingdom with BSE, it would be very difficult to 
prove susceptibility. In addition, it is unclear what the clinical presentation and 
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incubation period may be; leaving it difficult to prove conclusively that humans 
are not susceptible. And so, the precautionary principle is used regarding CWD’s 
potential risk to humans. It is advised that hunters not harvest animals that 
appear ill, and that they wear protective gear when dressing carcasses, avoiding 
contact with high risk tissues (brain, lymph tissue and spinal cord). It is also 
recommended that tissues from CWD-infected deer or elk are not used for 
animal or human food (WHO, 2002).  
 
2.1.11 Risk factors associated with chronic wasting disease 
a) Sex 
Studies of the sex distribution of CWD are limited as few regions harvest enough 
females to do good comparisons. Miller et al. (2000) did not find a large 
difference in prevalence between sexes in any of the three species studied. 
However, there appeared to be sex-specific differences between broad age 
classes of mule deer (<= 3 year old, >= 4 year old). This could be partly 
explained by disparity in underlying age structures from local hunting pressure on 
males (Miller et al., 2000). They did not show differences in infection proportions 
between male and female white-tailed deer and elk. 
 
b) Age 
Transmission appears to occur at any age via lateral transmission, and research 
supports adult cervids can contracting CWD (Miller et al., 1998; Miller et al., 
2000). Transmission can also occur at a very young age, but only rarely are 
yearlings clinically affected due to the extended incubation period (Williams, 
2005). Current testing strategies, when applied to animals younger than 1 year of 
age do not typically show a high prevalence in this population (Joly et al., 2006). 
As a result, only animals greater than 18 months of age are typically tested for 
CWD (Schettler et. al., 2006). 
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c) Spatial clustering 
Miller et al. (2000) found prevalence varied with spatial region, and tended to 
follow biologically relevant spatial patterns (lower elevation foothill 
subpopulations tended to be most severely affected). Joly et al. (2006) also 
found CWD to have a clustered spatial distribution in deer populations in south-
central Wisconsin. Spatial analysis for clustering identified a core-area of higher 
prevalence with a decline in prevalence from the center of the affected area; 
findings consistent with other horizontally transmitted diseases (Hickling, 2002; 
Joly et al, 2006). Joly et al (2006) hypothesized that the prevalence of CWD at 
any particular point is correlated with distance from introduction (as a surrogate 
for time) and local habitat conditions. Joly et al. (2006) also found that prevalence 
was positively correlated with the amount of deer habitat available.   
 
 d) Density 
The role of density in CWD transmission is unknown. It is believed that animal-
animal transmission is driven primarily by the average number of contacts per 
infectious individual per year, independent of density (Heesterbeek and Roberts, 
1995; McCarty and Miller, 1998; Miller et al., 2000). This is further supported by 
the fact that population reduction efforts, aimed at reducing density and reducing 
transmission, have not been successful in eliminating the disease (Miller et al., 
2000). However, it is foreseeable that cervid populations at higher densities, 
including artificial situations such as feeding sites and captive populations, would 
have increased contacts per year, hence increased transmission rates. A more 
recent study comparing prevalence rates from wild and captive cervid 
populations suggest that CWD transmission may be facilitated at higher cervid 
densities (Joly et al., 2006) which would act to increase the local prevalence of 
the disease. 
 
 e) Seasonality 
Affected animals are more commonly reported in the fall and winter (Williams, 
2005). It is unknown if this factor is associated with observational bias or with 
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increased environmental stress on already compromised CWD infected 
individuals.  
 
2.1.12 Geographic distribution  
Chronic wasting disease is not known to exist in wild cervid populations outside 
of North America, although surveillance in many countries is limited (Schettler et 
al., 2006; Roels et al., 2005).  Canadian CWD-infected game-farmed elk were 
imported by Korea however to date, no Korean-born deer have been reported 
with CWD (Kim et al., 2005). The current geographic distribution of known CWD-
positive free-ranging and game farmed cervids as of January 2009, is given in 
Figure 2. 
 
2.1.13 Origins of CWD 
CWD was first identified in Colorado in captive cervids as early as 1967 (Williams 
and Young, 1980). It was initially thought to be limited to captive wildlife facilities, 
however it was later discovered in free-ranging cervids in 1981 (Spraker, 1997). 
The source of the initial cases of CWD will never been known; the primary 
hypotheses include spontaneous generation, and mutation from other TSEs, 
such as scrapie (Kahn et al., 2004).  
 
2.1.14 History of CWD in Canada  
Since CWD was first identified in Colorado in the 1960s, the continent has 
watched the apparent geographic spread of this disease. CWD was first 
identified in Canada in 1980 at the Toronto zoo. This captive mule deer died in 
1978 after exhibiting signs consistent with CWD. Retrospective investigation 
identified an additional 7 mule deer and 1 black-tailed deer infected with CWD 
(Dubé et al., 2006). The most plausible source of introduction was the 
importation of infected animals from Colorado, although this has not been 
established conclusively (Dubé et al., 2006). No further cases of CWD were 
identified in Canada until 1996, when a game-farmed elk from Saskatchewan 
was presented for necropsy with a history of chronic weight loss and was 
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subsequently diagnosed with CWD. Another positive game-farmed elk was 
identified in 1998, and in 2000, a third case was diagnosed which led to 
identification of what is believed to be the source farm (index farm) responsible 
for transmission, either directly or indirectly, to a number of other farms. In 2000, 
an eradication campaign was undertaken which led to the destruction of over 
8000 animals on 40 farms. Epidemiologic investigation indicated that CWD was 
likely introduced into the farmed elk industry through importation of infected 
farmed elk from South Dakota in the late 1980s (Kahn et al., 2004).  
 
In response to the discovery of infected game-farmed elk, Saskatchewan Ministry 
of Environment (SMOE) conducted a survey in wild deer in the area surrounding 
the infected farm, all with negative results (CCWHC, 1998).  Experts at the time 
were hopeful that the disease was not present in the wild and that the outbreak 
had been adequately contained. It was estimated that the likelihood of infection 
being present in wild cervids was very low (CCWHC, 1996). However, the first 
case of CWD in a wild mule deer was identified in 2000 from the Manitou Hills 
region of western Saskatchewan near Lloydminster, close to the Alberta-
Saskatchewan border (CCWHC, 2001). This has led to speculation that CWD in 
wild cervid populations is a result of a ‘spillover’ from farmed cervids. Other 
possible sources of infection include sporadic occurrence, spillover from scrapie 
infected animals, and natural migration from southern infected populations (Kahn 
et al., 2004; Bollinger et al., 2004). 
 
2.1.15 Current Surveillance strategies for CWD 
Current CWD surveillance programs in wild cervids are based primarily on testing 
hunter-harvested animals. The advantage of this methodology is that samples 
can be collected and obtained at minimal cost. The samples are usually biased 
towards regions classified as higher risk (those regions known to be infected, 
adjacent to known infected wild populations, or regions adjacent to known 
positive game farms). Samples within regions are not random, as more mature 
males are usually harvested, and animals infected with CWD may be 
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overrepresented due to increased susceptibility to harvest (Conner et al., 2000; 
Williams, 2005).  
 
Another surveillance strategy used by some US wildlife jurisdictions is targeting 
and testing suspect animals, or “higher-risk” animals. This is typically done either 
through passive surveillance, relying on individuals to report any animals 
observed to be acting abnormally, or through a more active means, by collecting 
dead deer, including road kill and winter mortalities. One great advantage of 
targeted surveillance is that CWD-suspects have an increased probability of 
having the disease. One of the greatest limitations of this method is that this bias 
towards high risk animals makes interpretation of negative results difficult. A 
study conducted by Miller et al. (2000) compared testing of “suspect” deer and 
elk to hunter-survey deer and elk in CWD-endemic regions in Colorado from 
1978-1999. A deer or elk was considered a clinical suspect if they were ‘showing 
clinical signs consistent with CWD (=1.5 yr, poor body condition, abnormal 
behavior, ± other signs)’ (Miller et al. 2000).  “Clinically Suspect” deer were 13 
times more likely, and “clinically suspect” elk were 86 times more likely to be 
infected with CWD in areas with endemic CWD, when compared to deer 
harvested by hunters (Miller et al., 2000). The caveat was that local prevalence in 
a region needed to reach 1% before clinical cases were detected. There was no 
correlation between number of clinically suspect CWD cases detected and CWD 
prevalence (Miller et al., 2000). 
 
2.1.16 Current Management strategies for CWD 
Currently, there is no treatment or vaccine for CWD and disease control has 
been attempted by wildlife authorities largely through both movement restrictions 
to prevent new foci of disease, and heavy culling in affected areas. The primary 
goal of these culling programs is to reduce the prevalence of CWD or, at best, 
eliminate the disease in a geographic region. The assumption underlying this 
strategy is that transmission is density-dependant and that population reduction 
will reduce contacts between susceptible and infected individuals, and thus 
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reduce transmission (Joly et al, 2006). There is some evidence that density plays 
a role in transmission by influencing the frequency and intensity of interactions 
among deer within or among social groups (Joly et al, 2006; Hirth, 1977; Nixon et 
al, 1991; Grenier et al., 1999; Kie and Bowyer, 1999). However, factors such as 
breeding behavior, social interactions, movement patterns and practices that 
artificially concentrate deer result in a nonlinear relationship between density and 
contact rate, making it unlikely that population reduction would result in a linear 
reduction of disease transmission (Joly et al., 2006). Environmental persistence 
complicates efforts and act as a source of new infections, even when herd 
numbers are reduced drastically (Miller et al., 2004).  
 
Overall, efforts to date have been largely unsuccessful in eliminating the disease 
and controlling spread in wild populations, and new strategies need to be 
developed. Further information on deer behavior, dispersal patterns and disease 
transmission may provide insight into better recommendations for management 
of this disease.  
 
2.2. SURVEILLANCE FOR EMERGING WILDLIFE DISEASES 
2.2.1 Surveillance – definitions 
The term “surveillance” was first used during the French Revolution, when it 
meant “to keep watch over a group of persons thought to be subversive.” This 
term has been extended to animal health programs to define the process of 
watching over an animal population to determine whether a specific disease or a 
group of diseases makes an incursion.  It attempts to determine 
presence/absence of a disease and if a disease is present, changes in 
prevalence and the rate and direction of spread over time (Salman, 2003).  
 
Surveillance is ongoing, and includes observation, data collection, data analysis, 
and communication of results. There are three components of disease 
surveillance systems: 
 1) a defined disease monitoring system, 
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 2) a defined threshold of disease at which an intervention should 
    take place, 
 3) a defined set of interventions that will be undertaken when the threshold  
    is reached (Salman, 2003). 
 
‘A reliable surveillance system is the key to early warning of a change in the 
health status of any animal population. It is also essential in providing evidence 
about the absence of diseases or in determining the extent of a disease which is 
known to be present’ (Salman, 2003). Several types of surveillance methods 
exist, and are classified according to their function and data collection method 
(Salman, 2003). The methods chosen depend on the objectives of the 
surveillance program. 
 
2.2.2 Surveillance techniques 
Ultimately, the only way to know whether a disease exists in a population is to 
simultaneously test 100% of the population with a perfect test (100% sensitivity, 
100% specificity). This would only represent the disease status of the population 
at the time of testing, and would not account for the risk of introduction after that 
time. Testing of the entire population would need to be repeated on a continuous 
basis to provide up-to-date prevalence calculations, accounting for risk of 
introduction (Martin et al., 2007). For the large majority of cases this is not 
practical or possible and we are left with testing subsets of the animal population 
of interest which are used to make inferences about the population as a whole.  
 
The subset selected for testing largely depends on the goal of the survey. One 
method is simply to define the population, take a random sample and test those 
individuals. There are other techniques that randomly choose herds and test a 
number of individual animals within those herds. These methods are primarily 
done as surveys and have great surveillance value, especially when estimating 
prevalence in populations where the disease is known to exist. 
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a) Passive and active surveillance 
Passive surveillance is defined as a fixed, routine method which relies on 
veterinarians, meat inspectors, farmers and others to report suspicious cases at 
their discretion. Examples include submissions to a diagnostic pathology 
laboratory and reportable disease programs (Racloz, 2007). In the case of 
wildlife, conservation officers, hunters and members of the public comprise the 
front-line in disease detection. Despite their name, passive surveillance systems 
require a significant amount of effort to find ways and means of collecting and 
analyzing valuable information that may come out of these systems. They have 
the advantage of being relatively inexpensive, when compared to active 
surveillance systems, because the information is already being collected for 
some other reason. The greatest disadvantage of passive surveillance systems 
is that often the samples being collected are not representative of the entire 
population and information about the population from which the samples 
originated is often lacking. As a result, one must be cautious in interpreting the 
results at a population level.  
 
Passive systems are often used as the first step in identifying new and emerging 
diseases. When a new disease is introduced into a population, time to detection 
depends on the severity of clinical signs (morbidity and mortality), the familiarity 
of the individuals (conservation officers, hunters etc) with the clinical signs of the 
disease, and the speed with which the disease spreads (Salman, 2003).  
Stigmatized diseases, mild disease, diseases with non-specific clinical 
symptoms, long incubation periods, low within-herd and between-herd spread, 
and those diseases with unfavorable cost-benefit ratios, often have low case-
reporting levels; and thus are difficult to assess using passive surveillance 
systems alone. Doherr et al (2001) reported an increase in case-ascertainment 
and reporting of BSE suspect cases in Switzerland by the passive system after 
renewing awareness through continuing education workshops for practitioners 
and owners and by implementing targeted BSE screening at dead yards and 
changing the whole-herd culling policy in BSE positive herds. They believed that 
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without a targeted surveillance program, mandatory clinical suspect reporting will 
only capture <50% of the detectable cases. In other TSE diseases such as for 
scrapie in sheep and goats, underestimation levels between 30 and 87% have 
been reported (Schrueder et al., 1993; Hoinville et al., 1999; Baumgarten et al., 
2000).  
 
Active surveillance involves the purposeful collection of information, often 
targeting a specific disease. Surveys, sentinel systems and mass screening 
methods are examples of active surveillance (Racloz, 2007). This process 
produces more accurate estimates of frequency of disease such as incidence 
and prevalence, however they are often more expensive to implement.  
 
b) Probability and non-probability sampling 
Surveillance can also be categorized by the way the observation units are 
chosen: probability sampling (random) or non-probability sampling (non-random). 
Examples of non-random sampling include targeted and sentinel surveillance. 
For a disease such as BSE, which in Canada is rare, detection in the general 
population would require very large numbers of cattle to be tested in order to 
detect the disease. Targeted sampling of the bovine subpopulation considered at 
higher risk (4Ds- down, diseased, dying or dead) significantly improves the power 
to detect the disease.  
 
c) Risk-based surveillance  
The premise behind risk-based surveillance is: issues of higher risk are higher 
priorities for surveillance resources and as investments, also yield higher benefit-
cost ratios (Stärk et al., 2006). ‘In risk-based designs, public health, economic 
and trade consequences of diseases play an important role in selection of 
diseases or hazards. Furthermore, certain strata of the population of interest 
have a higher probability of being sampled for detection of diseases or hazards’ 
(Stärk et al., 2006). The goal of using risk-based surveillance is to maintain 
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efficacy of traditional systems, but improving their efficiency, thus better using 
resources.  
 
2.2.3 The importance of disease surveillance of wildlife    
Changing patterns of human behavior, such as urban development, production 
intensification and increased movement of biologic life, has accelerated and 
intensified emergence and spread of infectious diseases. Wildlife can serve as 
either the originating source, or the reservoir for significant diseases which 
impact human, domestic livestock or naïve wildlife populations. As a result, 
organizations such as the World Health Organization (WHO), the Food and 
Agriculture Organization of the United Nations (FAO) and the World Organization 
for Animal Health (OIE) have recognized the increased importance of wildlife 
health surveillance (FAO/WHO/OIE, 2004) and provided endorsement for 
enhancing wildlife monitoring and surveillance programs.   
 
a) Disease surveillance of wildlife to protect our ecosystem 
Disease is a normal part of a balanced ecosystem. However, human 
manipulation of ecosystems through activities such as habitat fragmentation, 
poaching, monoculture, and translocations has resulted in situations of 
imbalance which has fostered the emergence of new diseases or provided 
opportunity for diseases in situations where there weren’t previously. Wildlife 
populations can be used as indicators of ecosystem health, much akin to the 
‘canary in the coal mine’, and provide early warning of impending environmental 
disaster. 
 
b)  Disease surveillance of wildlife to protect public health 
Forty years after the ‘war on infectious disease’ was declared by top scientists to 
be over, emergence of new diseases such as acquired immunodeficiency 
syndrome (AIDS) and re-emergence of diseases such as tuberculosis left 
researchers bewildered. After such a drastic decline in infectious disease 
mortality since the early 1900s, no one would have predicted a 58% increase in 
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infectious disease mortality in the US from 1980-1992 (Pinner et al., 1996).  Of 
the infectious diseases considered to be emerging, 75% are zoonotic (Taylor et 
al., 2001) and wildlife populations provide a murky ‘zoonotic pool’ from which 
pathogens may emerge’ (Morse, 1995).  Diseases such as AIDS, SARS, plague, 
Nipah virus, West Nile virus, and Hendra virus are just a few examples of 
diseases thought to originate in wildlife populations (Jones et al., 2008).  
 
c) Disease surveillance of wildlife to protect livestock populations 
and trade  
There are many diseases known to infect both domestic and free-ranging 
populations, and many examples of spillover and spillback between the two 
compartments. Therefore, it is inevitable that diseases of importance to domestic 
animal health and trade will also have significance in wildlife populations. With 
the development of the Sanitary and Phytosanitary (SPS) agreement of the 
World Trade Organization (WTO) during the 1990s, countries are now required to 
provide scientific evidence documenting their disease status in order to improve 
fairness and transparency. A country can no longer claim disease-free status 
with a substandard disease detection system in place, and scientific evidence 
needs to be presented to substantiate disease freedom claims. In situations with 
an extended livestock-wildlife interface, disease-free claims may also include 
assessing high-risk free-ranging populations. If a free-ranging population is found 
to be infected with a listed OIE reportable disease, in absence of evidence of the 
disease in domestic populations, evidence must be put forth to substantiate 
compartmentalization of these two sectors to avoid trade restrictions.  
 
2.2.4 Wildlife disease surveillance – The Canadian Approach 
In response to increased national and international obligations to manage wildlife 
disease, the Canadian Cooperative Wildlife Health Center was formed in 1992 in 
Canada, to support wildlife disease surveillance, research and response.  These 
activities were further enhanced with the development of a national policy 
framework in 2004: the Canadian National Wildlife Disease Strategy (CNWDS). 
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This strategy aims to ‘minimize the negative impacts of wild animal diseases on 
biodiversity, human and livestock health, the environment and the economy’ 
(CNWDS, 2004). The six primary goals of managing wildlife disease in Canada, 
as outlined by the strategy are: 1) prevention, 2) early detection, 3) rapid 
response, 4) effective disease management, 5) education and training, and 6) 
communication. 
 
Monitoring disease in wildlife populations can be very challenging and expensive. 
Traditionally, passive surveillance systems or opportunistic sampling have been 
utilized as the keyhole through which we view wild animal health and disease. 
There are great advantages to such systems; they are relatively inexpensive, and 
coupled with education and awareness campaigns, they can yield good results 
(eg. West Nile virus dead wild bird surveillance program). Increased demand for 
wildlife disease information has placed increased pressure on these systems to 
produce reliable information, often requiring enhancements to existing systems.   
Like other veterinary disciplines, and perhaps even to a greater extent, wildlife 
health and management is further challenged with limited resources; hence the 
need for strategic risk-based surveillance plans to ensure efficient use of 
resources. 
 
2.2.5 Negative surveillance findings and probability of disease freedom 
In recent times, increased international trade between countries has resulted in 
increased demand for science-based assessments of a country’s disease status. 
In 1995, member countries of the World Trade Organization (WTO) developed 
the SPS agreement (http://www.wto.org/) which requires countries to 
substantiate claims of disease freedom with proof. Countries are not allowed to 
institute trade barriers without having scientific evidence that their population 
would be at increased risk should the trade in question be allowed. As mentioned 
previously, guaranteeing all animals in a population to be free of disease would 
require continuous census sampling with a perfect test; neither practical nor 
possible in most situations. 
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It has been accepted that negative findings in adequate numbers of 
representative animals (adjusting for imperfect test performance), is sufficient to 
claim ‘disease freedom’ with some confidence (that if the disease is present, it is 
below an acceptable threshold) (Martin et al., 2007). Disease freedom claims 
have historically been substantiated primarily through two methods; 1) qualitative 
reviews by expert panels of complex surveillance systems (including non-
representative samples, such as abattoir and targeted sampling methods), and  
2) quantitative analyses based on structured, representative surveys (Martin et 
al, 2007). Both have their disadvantages; qualitative reviews, although rigorous 
are difficult to repeat and may not be transparent, while structured surveys are 
often expensive, difficult to implement, and reliance solely on survey results 
ignores the potential value of other sources of evidence (Martin et al., 2007) 
Recently, Martin et al. (2007) proposed a quantitative approach by which multiple 
surveillance sources can be analyzed and integrated to develop a quantitative 
probability estimate to support claims of freedom of infection in a population, thus 
allowing better utilization of information obtained from non-representative 
surveillance systems.  
 
2.2.6 Evaluation of surveillance systems 
International standards for conducting surveillance provides guidance for 
decision making by animal health authorities and allows for comparison and 
evaluation of surveillance systems. Currently, there are standards set for only a 
few selected diseases such as rinderpest and contagious bovine 
pleuropneumonia (Anon., 1997; Anon., 1998). There are no surveillance 
standards for chronic wasting disease.  In the absence of surveillance standards, 
any surveillance system can be profiled by: objectivity, target population(s), 
design (sampling scheme and organization), diagnostic methods, analysis, and 
communication and feedback of results (Morris, 1991; Dufour and Audige, 1997; 
Dufour 1999; Stark, 2002). Once a surveillance system has been profiled and 
described, there are methods, qualitative and quantitative, which have been 
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proposed to further characterize the surveillance system in terms of quality. 
Regardless of methodology chosen, the approach must be objective, transparent 
and systematic (Salman, 2003). Hueston (1993) described an “ideal” surveillance 
system and then proposed that current systems could be compared with the 
“ideal” and scored accordingly. Dufour (1999) proposed using a similar scoring 
system, however, a more HACCP-like approach was taken, in which critical 
control points are identified and scored.  These techniques have been criticized, 
largely for their susceptibility to subjectivity. A more quantitative approach was 
taken first by Baldock (2000) and Hueston and Yoe (2000) which used scenario 
trees and stochastic simulation to describe the pathways of disease detection 
and to determine the probability of detecting an infected animal (Stark et al., 
2002). This technique has been further developed by Martin et. al (2007) allowing 
for multiple surveillance system components to be combined over multiple time 
periods to determine overall sensitivity. In order to gain the advantages of this 
method over more qualitative approaches there must be adequate, good quality 
data. Otherwise, the method is very similar to other approaches in subjectivity 
due to the use of expert opinion to fill in the missing data.  
 
Surveillance systems should be systematically evaluated to ensure the objectives 
of the program are being met as efficiently as possible. Especially in situations 
where resources are limited, a critical evaluation of a surveillance system can be 
very advantageous to ensure good use of resources. Possible motivations for 
doing quality assessments include designing a new system, improving an 
existing one (quality or cost-effectiveness), deciding on acceptance of data 
produced, and determining equivalence in the context of international trade 
(Salman, 2003). Detailed protocols for conducting evaluations of surveillance 
systems have been prepared by the CDC and Klaucke, et al. (1988). 
  
Despite their many uses, surveillance evaluations are highly underutilized in the 
veterinary field. It is the intent of the author to demonstrate the value of 
conducting surveillance evaluations in wildlife, and the different approaches to 
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evaluation will be explored in the context of CWD surveillance in free-ranging 
deer populations in Saskatchewan, Canada. 
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Figure 1 - Locations where chronic wasting disease has been detected in 
wild cervids (Odocoileus hemionus, Odocoileus virginianus, Cervus 
elaphus) in Saskatchewan 
 
Source: http://wildlife1.usask.ca/en/cwd/chronic_wasting_disease.php 
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Figure 2 - Distribution of chronic wasting disease in free-ranging and 
captive cervid populations in North America 
 
Source: http://www.nwhc.usgs.gov/disease_information/chronic_wasting_disease/index.jsp 
 
 
Source: http://www.nwhc.usgs.gov/disease_information/chronic_wasting_disease/index.jsp 
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3. TEMPORAL, SPATIAL AND DEMOGRAPHIC PATTERNS OF FREE-
RANGING DEER MORTALITY SUBMISSIONS TO A DIAGNOSTIC 
PATHOLOGY LABORATORY IN SASKATCHEWAN FROM 1966-2006 
 
3.1 ABSTRACT 
A retrospective study of free-ranging white-tailed deer (Odocoileus virginianus) 
and mule deer (Odocoileus  hemionus) submissions to a wildlife diagnostic 
pathology laboratory* from 1966-2006 was conducted to profile submission 
patterns in order to describe potential biases and to evaluate its use as a passive 
surveillance system to detect emerging diseases such as chronic wasting 
disease in wild cervids in Saskatchewan. Samples were characterized by 
species, year, type and nature of submission, age, sex, month submitted, 
geographic distribution, pathologic findings and data quality. Spatial and temporal 
patterns of submission were heterogenous for both species reflecting both 
natural events and artificial sampling bias. Sampling rates were low with a high 
degree of variability by season, year, location and nature of submission. Poor 
data quality reduced the amount of available data for analysis but quality 
dramatically improved over time as there was increased desire to use this system 
for surveillance.  Measures to improve both quality and quantity of information 
would improve this passive surveillance system and its ability to detect disease.    
 
* 1966-1995 – Western College of Veterinary Medicine- Department of Pathology 
  1996- 2006- Canadian Cooperative Wildlife Health Centre 
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3.2 INTRODUCTION 
For over 40 years, wildlife pathologists in Saskatchewan at the Western College 
of Veterinary Medicine (WCVM) (52 Campus Drive Saskatoon, SK, Canada 
S7N 5B4) have been investigating morbidity and mortality events in wildlife 
through submissions of carcasses for diagnostic pathology. The primary 
objectives of these investigations have been to advise managers (wildlife and 
domestic), conservation officers and hunters on issues related to infectious 
disease, metabolic disease, food safety, and forensic science. Secondary to this, 
these submissions form what is described in the literature as a passive 
surveillance system which can be used to monitor populations over time and to 
detect and describe significant diseases. There is little dispute that these passive 
surveillance systems play an important role in disease discovery, however the 
efficacy and efficiency of these systems are highly variable and depend on a 
number of factors associated with both the disease itself and the strength of the 
surveillance system. Identifying limiting factors which reduce the sensitivity of a 
system is important for interpretation of surveillance outcomes and for 
strengthening surveillance systems. 
 
In Saskatchewan, wild cervids, such as white-tailed deer (Odocoileus virginianus) 
and mule deer (Odocoileus hemionus) make up a large proportion of the 
surveillance submissions. Both species are abundant and are a valued resource, 
contributing an estimated 3 million dollars to the local economy yearly in hunting 
revenues (Arsenault, 2005).  Estimated populations for 2003 in the province were 
approximately 369 000 white-tailed deer and 43 000 mule deer (Arsenault, 2005). 
The ranges of the two species overlap; white-tailed deer have a large range, 
which covers most of the entire southern half of the province, while mule deer are 
more concentrated in the south-west (Figures 1 and 2).  
 
Surveillance in Saskatchewan of these two species in particular, has led to 
several diseases being first described in Western Canada, such as 
necrobacillosis (Wobeser et al, 1975), polioencephalomalacia (Wobeser and 
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Runge, 1979), and dermatomycosis (Wobeser et al., 1983). Necrobacillosis was 
discovered when an outbreak caused significant mortality in a localized region of 
the province (Wobeser et al., 1975). Dermatomycosis (ringworm) is highly visible 
and easy for hunters and conservation officers to spot. Polioencephalomalacia 
results in neurologic signs which typically concern observers. All three diseases 
had factors which increased the likelihood of being detected; they were highly 
visible because they affected a large number of animals, or were easy to 
recognize.  
 
Unlike livestock populations, free-ranging populations are not under constant 
“vigilance”. The probability of observing a free-ranging animal that is ill or dead 
may be dependent on factors such as the size of animal, time of year and foliage 
cover. Further to that, vigilance is greatly affected by the distribution and density 
of the human population. In Saskatchewan, the population density is one of the 
lowest in Canada and is largely concentrated around urban centers. The majority 
of the rural municipalities average less than 1 person per square kilometer 
(http://esask.uregina.ca/entry/population_trends.html), resulting in a decreased 
likelihood of observing an animal in rural areas. Once an animal is “observed”, 
the training and awareness of the observer, along with their level of concern will 
impact their decision as to whether to contact wildlife authorities or not. Whether 
a wildlife authority responds or not may be a function of logistics, funding and 
level of awareness or education. The resulting spatial and temporal variation in 
surveillance “vigilance” may impair disease detection. For example, chronic 
wasting disease (CWD) was not detected through this surveillance system until 
2005; more than 5 years after it was first discovered in free-ranging populations 
using hunter-harvest submissions (Trent Bollinger, personal communication). 
Further exploration of the submission patterns may provide insight into strengths 
and limitations of this system, including how to improve it for the purposes of 
disease detection. 
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The primary objective of this study was to characterize the amount and 
distribution of white-tailed and mule deer samples submitted from Saskatchewan 
to a provincial laboratory for diagnostic pathology from 1966-2006. A descriptive 
analysis was conducted to describe sample submissions by species, type of 
submission, sex, age, month of submission, geographic distribution, and 
pathologic diagnosis. The intent of this analysis is to describe patterns of 
submissions to this surveillance system, and how they may have changed with 
time. The use of this system to detect emerging diseases, such as was the case 
for CWD in the late 1990s and early 2000s will be examined. This information will 
also be used in the qualitative and quantitative evaluation of CWD surveillance 
systems.  
 
3.3. MATERIALS AND METHODS 
All records of cases originating in Saskatchewan from 1966-2006 submitted for 
pathology examinations to the Saskatchewan provincial diagnostic services1 
under the category white-tailed deer, mule deer, or deer (non-specified) were 
examined. A total of 2163 free-ranging deer were submitted by conservation 
officers, hunters, biologists and public patrons during that time period.  
Information obtained from the records was recorded in a database (Microsoft 
Office Excel 2003) and included information on species, nature and type of 
submission, history, date found, date submitted, age, weight, sex, body condition, 
geographic location, necropsy findings and pathologic diagnosis. 
 
Routine post-mortem examination typically included species identification or 
verification, age and sex determination, and body condition scoring. Age was 
primarily determined using examination of tooth enumeration and wear, and 
varied with examiner experience and sample availability. The body condition 
score for carcasses was determined by the examining pathologist and was 
classified as (1) very good, (2) good, (3) fair, (4) poor, or (5) very poor.  
                                            
1 1966-1995 – Western College of Veterinary Medicine- Department of Pathology  
   1996- 2006- Canadian Cooperative Wildlife Health Centre  
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All whole or partial carcasses received a thorough gross pathologic examination, 
followed by tissue/sample collection for histopathologic, bacteriologic, parasitic or 
viral evaluation in selected cases. In cases where only selected tissue samples 
were submitted, examination was limited to those tissues and a limited diagnosis 
was made. 
 
Upon complete examination of the specimen, results were interpreted and a 
primary and secondary diagnosis (in selected cases) was given.  In order to 
facilitate interpretation for the purposes of this study, the primary diagnoses were 
further grouped into the following categories: trauma, infectious/inflammatory, 
emaciation/starvation, unknown/no diagnosis, survey (various), poisoning 
toxicity, neoplasia, anomalies, and other. 
 
For mapping purposes, samples were aggregated at point locations and mapped 
by species for the periods before CWD was discovered in free-ranging 
populations (1966-1999) and after (2000-2006). Kernel estimation was used to 
generate raster maps and account for point density at specific locations and 
demonstrate geographic concentrations or hot spots of sampling.  
 
Geographic location where the animal was found was recorded and geographic 
coordinates (latitude/longitude) were assigned. All submissions with location 
information were mapped, accounting for multiple submissions originating from 
some locations. Samples were also categorized according to the quality of 
location information: 0) very poor; only location of natural resource office, 1) poor; 
general area (closest town) where the animal was found, 2) fair; specified area 
(distance and direction from closest town) where the animal was found, and 3) 
good; exact location provided (latitude/longitude coordinates or land location 
information).  
 
Descriptive statistics were generated using SPSS for Windows, Rel. 14.0.0.2005. 
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Chicago: SPSS Inc.. Maps were generated using ArcGIS Desktop (Version 9.3. 
Redlands, CA: Environmental Systems Research Institute, 1999-2008). 
 
3.4 RESULTS 
A total of 2163 samples of free-ranging white-tailed deer, mule deer and 
“deer/non-specified” were submitted from 1966-2006. White-tailed deer 
comprised the majority of the submissions (1715 – 79.3%), followed by mule 
deer (317 – 14.7%) and “deer” non-specified (131 – 6.1%). The two free-ranging 
deer species present in the province of Saskatchewan are white-tailed deer 
(Odocoileus virginianus) and mule deer (Odocoileus hemionus), therefore those 
submitted under the category “deer/non-specified” were assumed to be of either 
species; however information on age, sex, and location obtained from samples 
submitted under “deer/non-specified” was of poor quality and therefore these 
records were excluded from the remainder of the analysis (n=131).     
 
The number of samples submitted fluctuated yearly in both species. Sample 
submissions for white-tailed deer ranged from 1-227 per year with a median of 31 
samples per year (Figure 3), while sample submissions for mule deer ranged 
from 0-37 samples per year with a median of 6 samples per year (Figure 4).  
 
Information on the month when the animal was found was compared to the 
month submitted to determine if a significant amount of time often elapsed 
between the two events. Of those records with both dates provided,1133/1275 
(88.9%) were submitted = 31 days after they were found and 142 samples 
(11.1%) were submitted >31 days after being found. Therefore, because the date 
in which the animal was found (or shot) was missing for a number of 
submissions, date of submission was used as a proxy when estimating the 
season in which the animal died. The majority of samples were submitted from 
November through April (88.7% WTD; 82.3% mule) with few samples being 
submitted from May to October (late spring/summer/fall) (Figure 5).  
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Samples were examined to determine the age and sex distribution of 
submissions. A total of 1711 (84.2%) cases provided information about age 
(missing n=321); and 1845 samples contained information on sex. Results are 
compared (Table 1) with provincial age structure estimates based on annual 
Cooperative Deer Management Survey (CDMS) field observations (September –
November) (Arsenault, 2005).   
 
In total, there were 1515/1715 (88.3%) white-tailed deer samples and 275/317 
(86.8%) mule deer samples with location information ranging from very poor to 
good quality. On average, the location information provided at time of submission 
was of low quality (Figure 6). The quality of location information substantially 
improved with time. 
 
The maps of sampling density (Figure 7) reflect heterogenous sampling across 
time and space; partly due to the distribution of deer in the province, to specific 
events such as outbreaks, but also in part due to other human factors. Some 
conservation officers were very interested in participating in the mortality/parasite 
studies, thus sending in higher numbers of WTD samples from the Harris area 
(west central) in 1970-72 and the Hudson bay area (east central) in the years 
1974-79. The WTD cluster in the SE corner in the Moose Mountain, Carlyle and 
Estevan area was due to multiple submissions over many years. There was no 
distinct reason discernible for these increased submissions; however it could 
reflect high deer density, natural events causing high mortality, or specific 
individuals with a keen interest in mortality events. After 2000, the spatial pattern 
of sampling changed. The discovery of CWD in a wild mule deer in Lloydminster 
area increased submissions from that area, and this is reflected in the map. For 
WTD, approximately 50% of deer submitted from the Prince Albert, Nipawin and 
Love areas were submitted in 2005 and 2006, after CWD was discovered in the 
wild in that region. 
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The five most common categories of pathologic diagnoses were: trauma 
884(43.5%), infectious/inflammatory/metabolic processes 465 (22.9%), 
emaciation/starvation 254(12.5%), other 145 (7.1%) and unknown/no diagnosis 
129(6.3%). Pathologic findings are summarized in Table 2. 
 
Traumatic injuries were further categorized: motor vehicle collisions accounted 
for 46.3% of all traumatic injuries (n= 409), while gunshot wounds (n=147; 
16.6%), and predators (n=136; 15.4%) were also significant causes of trauma. 
Generalized trauma of unknown origin was diagnosed in 192 (21.7%) cases. 
 
The infectious/inflammatory conditions category was further stratified, with local 
inflammatory conditions such as abscesses being the predominant diagnosis 
(Table 3). Disease conditions such as dermatitis (dermatophycosis), 
necrobacillosis, rumenitis and polioencephalomalacia represent a significant 
proportion of submissions under this category and reflect study interests of 
researchers. 
 
Clinical history was limited in most submissions; with the majority of submissions 
either “healthy” (shot by hunter) or found dead. There were a number of cases 
submitted with a history of neurologic signs (limited flight response, aggression, 
ambulatory difficulties, salivation). Historically, rabies has always been a primary 
concern in cases presenting with neurologic signs. More recently 
polioencephalomalacia (1990) and chronic wasting disease (2000) have been 
added to the list of differentials.  These diseases are of increased concern to the 
public, and as a result, clinically neurologic animals are thought to have relatively 
high submission rates. The submission rates for white-tailed deer and mule deer 
exhibiting clinical disease with neurologic signs is given in Figure 8.  
 
3.5 DISCUSSION 
This retrospective review demonstrates the variability that can occur with passive 
surveillance systems and their resulting limitations. The greatest limiting factor of 
this passive surveillance system is sampling rate; rates in both species were 
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highly variable and overall, low. Submission rates were heavily impacted by both 
natural events such as outbreaks or harsh winters, but also by ‘artificial’ events 
such as special studies and surveys.  
 
Rates of submission also were highly variable throughout each year. The marked 
seasonality of sample submissions (November through April) could reflect true 
increases in mortality but could also be due to observational bias. Previous 
studies suggest that mortality rates are much higher during these months, with 
increasing risk over the course of the winter due to harsh climatic conditions and 
resource scarcity (DelGuidice et al., 2002). Additionally, the primary hunting 
month is November which accounts for a significant amount of mortality, 
especially among adult bucks. Another explanation for seasonality of 
submissions is that there is an increased probability that the animal will be found 
and submitted with better carcass visibility and preservation in the colder months. 
Likely both observation bias and increased mortality contributed to the 
seasonality of submissions.  
 
Bucks greater than 1 year of age were overrepresented in this sample, relative to 
the estimated age and sex distribution of the underlying population. This could 
reflect a true increase in mortality rates or alternatively could be due to 
observational bias, as hunters are more likely to shoot bucks, and therefore 
observe pathologies associated with them. Increased submission rates among 
bucks is somewhat expected due to increased hunting pressure, including 
forensic investigations and deaths secondary to non-fatal gunshot wounds.  
 
The spatial distribution appeared to be less dependent on urban populations than 
originally hypothesized. After 2000, there does appear to be an increased 
number of WTD samples submitted from areas surrounding Regina and 
Saskatoon (the most populous cities in Saskatchewan), but overall the majority of 
hot spots were dependant on deer densities, disease discovery (CWD), surveys 
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and conservation officers.  All these factors must be considered when 
interpreting surveillance findings.  
 
 
The most commonly reported pathologic diagnosis was trauma. This included 
gunshot wounds, vehicular collisions, predation, and trauma of unknown origin. 
This is similar to radiotelemetry findings, where gunshot wounds, vehicular 
collisions and predation have been reported to be significant causes of mortality 
(Bleich and Taylor, 1998; Pusateri Burroughs et al., 2006). Following trauma, 
infectious/inflammatory disease was the second most common disease finding. 
This was largely due to hunter submissions of localized lesions for determination 
of wholesomeness of the carcass. The nature of submissions fluctuated over 
time, with more samples submitted with a history of neurologic disease following 
the identification of CWD in free ranging populations.  
 
Data quality overall, was a limiting factor in this analysis and accounted for a 
significant reduction in the amount of data available. There are many factors 
contributing to this. In some situations, scavenging and degradation of carcasses 
prevented determination of age, sex, body condition or diagnosis. In other 
situations, the information was likely available, however was not recorded at the 
time of collection. The majority of samples (approximately 85%) appeared to 
have been submitted by conservation officers, although information on the type 
of submitter was not directly collected.  In general, information obtained from 
hunters was of poor quality, likely due to the specific nature of their 
investigations. Often, hunters would only send the relevant portions of carcasses 
with pathology with specific questions in mind, and were less likely to provide 
information on species, age, sex, and body condition. Information received from 
surveys, such as winter mortality studies, was also of poorer quality.  This could 
have been because multiple deer were often collected at once, and individual 
characteristics were difficult to keep organized. Alternatively, individual 
characteristics may not have been thought to be important, and therefore less 
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attention may have been taken towards noting details such as exact geographic 
location, because harsh winter conditions were consistent throughout a region. 
Overall, the poor quality of location information limited the extent of spatial 
analysis that could be conducted. Quality improved following the formation of the 
Canadian Cooperative Wildlife Health Center, and continued to improve with the 
development of chronic wasting disease surveillance programs. The quality of 
data improved considerably over time, as more effort was put towards using 
these records for surveillance purposes. Data quality has been identified as an 
ongoing challenge with current surveillance programs (Trent Bollinger, personal 
communication), and value of sufficient resources and attention put towards 
standardizing data collection can not be overstated.  
 
Despite their limitations, passive surveillance systems can be a valuable source 
of information about the population under surveillance and have contributed to 
the discovery of important diseases. Where they seem to work best is in 
diseases with high prevalence in the population and/or that are highly visible and 
easily recognizable. Because this system relies on human observation, 
conditions which increase the likelihood of human interaction, both spatially and 
temporally, are more likely to be detected. This has been demonstrated here with 
diseases such as grain overload, rabies, polioencephalomalacia, and chronic 
wasting disease. Diseases such as anthrax and epizootic hemorrhagic disease 
(EHD), which primarily occur in the warmer, drier months are less likely to be 
detected for a variety of reasons (Beringer et al., 2000). Increased temperatures 
would degrade the carcass faster, reducing both the quality of the specimen and 
the likelihood that an observer would approach it.  There is also more foliage 
reducing visibility.  Alternatively, diseases which are more likely to occur in the 
colder months are more likely to be detected, with better preservation of 
carcasses and reduced foliage. Vigilance also increases during hunting season, 
as more people are out observing deer (eg. Chronic wasting disease is more 
commonly reported in the fall and winter (Williams, 2005)).    
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Therefore, although chronic wasting disease spreads slowly and takes time to 
increase in prevalence, it is likely to be detected among passive surveillance 
because of the neurologic changes that occur in an infected deer. Clinical CWD 
animals are more likely to wander into yards (Trent Bollinger, personal 
communication) and less likely to avoid motor vehicle collisions and predator 
attacks (Krumm et al., 2005; Williams, 2005). The most likely reason that it was 
not detected early in Saskatchewan through this surveillance system is that there 
were simply not enough samples being submitted with consistency.  In white-
tailed deer, submission rates did not increase overall in 1996 (after CWD was 
discovered in farmed cervids) or in 2000 (after CWD was discovered in a wild 
cervid) but the nature of submissions did shift more towards animals acting 
abnormally. This shift is much more dramatic in mule deer, especially after 2000. 
Both submission numbers and submissions of animals acting abnormally 
increased following detection of CWD, reflecting increased ‘vigilance’ and 
concern for chronic wasting disease in this population.  
 
 
CONCLUSION 
 
With demands for wildlife surveillance information increasing and diversifying, 
laboratory submission-based passive surveillance systems, such as this one, 
could play an increasingly important role in disease discovery and monitoring as 
non-random sampling, or targeting of the “3D” (diseased, dead, dying) subset of 
the population can be a very efficient approach to detecting new diseases at low 
prevalence. In Saskatchewan, spatial, temporal and demographic submission 
patterns were variable and heavily dependent on specific, intermittent research 
projects. Although these projects were very valuable in providing resources that 
otherwise would not have been available for wildlife disease surveillance, they 
ultimately affected the surveillance outcomes. This system could be greatly 
enhanced by improving submission rates across all regions and acquiring better 
quality information. It follows that more consistent funding of surveillance of 
wildlife populations would dramatically improve these systems. 
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Figure 1 - White-tailed deer range map showing habitat and management 
units (Source: Saskatchewan Ministry of the Environment)  
 
 
 
 
 
 
 41 
Figure 2 - Mule deer range map showing habitat and management units 
(Source: Saskatchewan Ministry of the Environment)  
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Figure 3 - Number of white-tailed deer samples submitted per year in 
Saskatchewan from 1966-2006 
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**increased mortality due to starvation, necrobacillosis, grain overload and trauma  
 
 
Figure 4 - Number of mule deer samples submitted per year in 
Saskatchewan from 1966 – 2006  
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Figure 5 - White-tailed deer and mule deer submissions from Saskatchewan 
by year and month 
 
 
 
 
Table 1 - Comparing sex and age ratios of the pathology samples and the 
general population  
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0.87 
0.43 
(Range: 0.32-0.47) 
 
1.4 
0.47 
(Range: 0.38-0.55) 
 
Fawn/doe 
 
1.05 
0.94 
(Range:0.8-1) 
 
0.81 
0.79 
(Range: 0.69-0.92) 
 
 
 
 
 
 
Dec Nov Oct Sep Aug Jul Jun May Apr Mar Feb Jan 
Month submitted 
120 
100 
80 
60 
40 
20 
0 
N
um
be
r o
f S
ub
m
is
si
on
s 
2006 
2005 
2004 
2003 
2002 
2001 
2000 
1999 
1998 
1997 
1996 
1995 
1994 
1993 
1992 
1991 
1990 
1989 
1988 
1987 
1986 
1985 
1984 
1983 
1982 
1981 
1980 
1979 
1978 
1977 
1976 
1975 
1974 
1973 
1972 
1971 
1970 
1969 
1966 
 
 44 
Figure 6 - Quality of location information provided at time of submission: 
Proportion of very poor, poor, fair and good quality information by decade 
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Figure 7 - Spatial distribution of white-tailed deer and mule deer samples 
submitted before (1966-2000) and after (2001-2006) CWD was discovered in 
wild cervid populations  
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Table 2 - Pathologic diagnosis among white-tailed and mule deer submitted 
from 1966-1996 
 
Pathologic Diagnosis Frequency Proportion 
Trauma 884 43.5 
Infectious/inflammatory 465 22.9 
Emaciation/starvation 254 12.5 
Other 145 7.1 
Unknown/no diagnosis 129 6.3 
Survey (various) 118 5.8 
Poisoning/toxicity 23 1.1 
Neoplasia 8 0.4 
Anomalies 6 0.3 
TOTAL 2032 100 
 
 
Table 3 - Breakdown of infectious, inflammatory, and metabolic conditions 
by category of disease or specific condition 
 
 
 
 
 
 
 
 
 
Diagnosis Frequency Proportion  
Focal inflammation (various locations, eg. abscesses)  101 21.9 
Dermatitis (including dermatomycosis) 59 12.8 
Other systemic disease (various) 53 10.8 
Necrobacillosis 48 10.4 
Rumenitis/grain overload 44 9.5 
Pneumonia 41 8.9 
Encephalopathy (brain abscess, meningitis, and 
others) 
35 7.6 
Polioencephalomalacia 29 6.2 
Fibropapilloma 28 6.1 
Parasitism 22 4.7 
Chronic wasting disease 4 0.9 
Epizootic hemorrhagic disease 1 0.2 
TOTAL 465 100 
 47 
Figure 8 - White tailed deer and mule deer submissions with a history of 
abnormal behavior from 1966-2006  
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4. SURVEILLANCE SYSTEMS FOR CHRONIC WASTING DISEASE IN FREE-
RANGING MULE AND WHITE-TAILED DEER IN SASKATCHEWAN: 
A QUALITATIVE EVALUATION  
 
 
4.1 Abstract 
A qualitative evaluation of chronic wasting disease (CWD) surveillance in free-
ranging Saskatchewan mule and white-tailed deer was conducted in order to 
describe the surveillance system components, appraise the system’s ability to 
detect CWD in new areas and monitor trends over time, and make 
recommendations to improve the system. The evaluation was conducted using 
information gathered from a descriptive analysis of surveillance results (1997-
2006) and key informant interviews. The two main components of the 
surveillance system include hunter-harvested sampling of ‘healthy’ animals and 
pathology submissions of clinically ill animals (dead, diseased, dying- 3D). 
Hunter-harvested samples comprise the majority of the submissions and have 
detected almost all the CWD-infected animals to-date. Additionally, this 
surveillance component can be used to monitor trends in infected areas over 
time. Although the 3D surveillance component has not detected many cases, it is 
currently significantly limited by very low submission rates. Surveillance on 
clinically ill cervids, including CWD suspects, is a more efficient way to detect 
CWD in regions where the prevalence is low, and increasing submission 
numbers will greatly improve the sensitivity of this surveillance system.   
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4.2 INTRODUCTION 
The demand for wildlife disease information has both intensified and diversified in 
recent years, resulting in the need to prioritize surveillance activities in the face of 
limited resources. The concept of ‘risk-based surveillance’ whereby diseases or 
issues that present higher risks merit higher priority for surveillance resources 
has been widely accepted and with this comes the need for surveillance systems 
that are both efficacious and efficient at meeting stated objectives. Regular, 
systematic evaluations of surveillance system attributes can help to ensure 
surveillance systems are meeting objectives and identify any areas where 
improvements can be made.  In Canada, chronic wasting disease (CWD) was 
first discovered in elk in 1996 on a Saskatchewan game-farm. Surveillance 
began in free-ranging deer in earnest in 1997 in the areas surrounding the 
positive game farm to determine if the disease also existed in wild populations. 
Surveillance activities later expanded, and in 2000, a CWD-positive free-ranging 
mule deer (Odocoileus hemionus) was found. A formal evaluation of CWD 
surveillance in Saskatchewan has never been conducted. This evaluation will 
briefly detail the background on CWD, describe the current CWD surveillance 
objectives and components for free-ranging mule (Odocoileus hemionus) and 
white-tailed deer (Odocoileus virginianus), evaluate the attributes of the 
surveillance system components, and provide recommendations based on the 
findings.  
4.3 BACKGROUND 
Chronic wasting disease (CWD) is a fatal, infectious, neurodegenerative prion 
disease (transmissible spongiform encephalopathy; TSE) that affects both free-
ranging and captive cervid species in North America. It was first identified in 
Colorado, USA in captive cervids as early as 1967 (Williams and Young, 1980). 
Since that time, the continent has watched the apparent geographic spread of 
this disease; efforts to control CWD have thus far been largely unsuccessful 
(Figure 1). 
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Current geographic distribution of CWD in Saskatchewan free-ranging deer 
populations 
At the time when CWD was initially discovered in free-ranging populations in 
Saskatchewan (2000), it was believed to be a localized outbreak resulting from a 
spill-over from the infected game-farm (Trent Bollinger, personal communication). 
From 2000-2006, CWD was identified in 114 wild mule deer (O. hemionus) and 
36 white-tailed deer (O. virginianus), primarily in 3 regions in the province near 
the Lloydminster, Saskatchewan Landing and Nipawin areas (Figure 2).  
 
Importance for free-ranging and game-farmed deer populations 
Chronic wasting disease in free-ranging populations has affected both the free-
ranging populations themselves and the trade and production of captive cervids. 
CWD doesn’t appear to be self-limiting and the long-term affects are predicted to 
result in a significant decline in deer population numbers (Miller et al., 2000). 
Additionally, a decline in deer populations would result in decreased hunting 
revenues which ultimately would reduce available resources to support wildlife 
management programs under current funding conditions. CWD has also had an 
impact on trade of Canadian captive cervids and their products, resulting in a 
dramatic decline in the value of the industry (Kahn et al., 2004). 
 
Implications for human health  
The transmissibility of CWD to humans via dressing of carcasses and 
consumption of infected meat and organs is unknown. There is currently no 
strong evidence to suggest that humans are susceptible to CWD (Belay et al., 
2001; Belay et al., 2003; Belay et al., 2004; MaWhinney et al., 2006), however as 
with BSE, it is possible that humans are highly resistant to CWD infection, but still 
susceptible. And so, the precautionary principle is used regarding CWD’s 
potential risk to humans. It is advised that hunters not harvest animals that 
appear ill, and that they wear protective gear when dressing carcasses, avoiding 
contact with high risk tissues (brain, lymph tissue and spinal cord). It is also 
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recommended that any tissue from a CWD-infected deer or elk is not used in 
animal or human food (WHO, 2000).  
 
Controlling the spread of CWD 
Disease control activities in multiple jurisdictions including Saskatchewan, and 
Alberta, currently rely primarily on density reduction. It is felt that delays in CWD 
detection in new areas would facilitate further disease transmission by allowing 
for the exposure of adjacent susceptible populations.  
 
The Canadian Cooperative Wildlife Health Center and the Canadian National 
Chronic Wasting Disease Strategy 
The Canadian Cooperative Wildlife Health Center (CCWHC) was created in 1992 
in order to ensure a collaborative and coordinated approach to wildlife disease 
surveillance, research and response in Canada. In response to increased 
concern about CWD in Canada, the Canadian National Chronic Wasting Disease 
Strategy (CNCWDS, 2005) was developed to identify common goals in dealing 
with CWD, and to provide a coordinated national policy and disease 
management framework. ‘The ultimate objective of the strategy is to eradicate 
CWD from Canada, or failing this, to achieve the tightest possible control of the 
disease so that it does not spread to new geographic areas or to new species, in 
order to minimize environmental, economic and health impacts’ (CNCWDS, 
2005).  The six primary goals of managing CWD in Canada, as outlined by the 
CNCWDS are: 1) prevention, 2) early detection, 3) planned response, 4) effective 
disease management 5) education and training and 6) communication. 
 
Challenges for CWD surveillance in Saskatchewan 
At the time the strategy was developed, CWD was considered to be present at a 
low prevalence in a relatively small, defined geographic region; and as such, 
surveillance efforts were largely concentrated in that region. As the geographic 
range continues to increase, there is increased demand on the surveillance 
system, effectively thinning out resources across a larger geographic area.  
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4.4 SURVEILLANCE EVALUATION OBJECTIVE 
To evaluate CWD surveillance in white-tailed deer (Odocoileus virginianus) and 
mule deer (Odocoileus hemionus) in Saskatchewan and assess if current CWD 
surveillance objectives are being met. 
 
4.5 CWD SURVEILLANCE AUTHORITIES AND STAKEHOLDERS  
The data collected on the status of deer populations in Saskatchewan is primarily 
used by wildlife management organizations (Saskatchewan Ministry of 
Environment (SMOE), Canadian Wildlife Service, Parks Canada), hunters, 
domestic livestock organizations (Saskatchewan Agriculture and Food, Canadian 
Food Inspection Agency), wildlife research groups (Canadian Cooperative 
Wildlife Health Centre (CCWHC), University of Saskatchewan, University of 
Alberta), the provincial laboratory (Prairie Diagnostic Services (PDS)) and public 
health organizations (Public Health Agency of Canada, Health Canada).  Hunter-
harvested sampling is coordinated and funded primarily through Saskatchewan 
Ministry of Environment. All testing is conducted by pathologists in the Canadian 
Cooperative Wildlife Health Centre, in cooperation with Prairie Diagnostic 
Services. Results and demographic information are organized and stored in the 
CCWHC databases.  
 
4.6 METHODS 
The surveillance system evaluation was conducted, using a format and criteria 
previously outlined by Klaucke et al. (1988) and German et al. (2001). The 
evaluation consists of three parts: 1) describing or profiling the surveillance 
system in terms of objectives, purpose, system components, case definitions, 
outputs and resources, and 2) conducting a performance evaluation using the 
desired system attributes (simplicity, flexibility, data quality, acceptability, 
sensitivity, predictive value positive, representativeness, timeliness, and stability) 
and 3) synthesizing information in order to make conclusions and 
recommendations. 
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In order to describe and evaluate the surveillance system components, 
interviews were conducted with key stakeholders. The stakeholders included: the 
Canadian Cooperative Wildlife Health Center’s CWD surveillance program 
manager, the program data manager, the Director of Policy, Finance and 
Administration, the IT Manager and Saskatchewan Ministry of Environment. 
CCWHC diagnostic laboratory reports and CWD testing results were also 
reviewed.    
 
4.7 OBJECTIVES FOR CWD SURVEILLANCE IN FREE-RANGING MULE AND 
WHITE-TAILED DEER (as outlined in the Canadian National CWD Strategy): 
1)  Early detection of CWD at a low prevalence in cervid populations in order 
to rapidly intervene and to maximize effectiveness of control measures, 
including minimizing costs and economic losses.  
2)  To gather information on CWD in infected populations to assist in 
management decisions including monitoring the spatial and temporal 
trends in prevalence, disease transmission dynamics and the impact of 
disease control efforts. 
3)  To identify critical areas for further research in CWD to assist with early 
detection and effective management of this disease.  
 
4.8 THE EVENT UNDER SURVEILLANCE 
For the purposes of this evaluation, the population under surveillance is all white-
tailed deer (Odocoileus virginianus) and mule deer (Odocoileus hemionus) in 
Saskatchewan. A positive surveillance outcome is the detection of a CWD-
infected mule or white-tailed deer in Saskatchewan.  Immunohistochemistry is 
the current gold standard for CWD testing, and a case is considered to be CWD-
positive if any neural or lymphoidal tissue stains positive. The target tissues most 
commonly tested include the tonsil, retropharyngeal lymph node and obex. 
4.9 COMPONENTS OF THE CWD SURVEILLANCE SYSTEM  
Prior to 1997, there was not a surveillance system in place specifically for CWD. 
There was, however, a passive multi-disease surveillance system that relied on 
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submissions of clinically ill (dead, diseased, dying) animals; this passive 
surveillance system is still in place. In 1997, in response to the discovery of the 
CWD-positive game farmed elk, a small hunter-harvest survey was conducted in 
areas surrounding a CWD positive game farm, with negative results. Regional 
hunter surveys continued through 1998 and 1999, and in 2000, a free-ranging 
mule deer was diagnosed with CWD. After this discovery in 2000, the hunter-
harvested surveillance component was substantially expanded. Today, this is the 
primary means of conducting CWD surveillance. Currently, the surveillance 
system in place for chronic wasting disease (CWD) in wild cervids consists of 
these two components: 1) clinical surveillance which involves testing dead, 
diseased or dying animals (3D) that are found by members of the public, hunters 
or conservation officers, and 2) hunter-harvest surveillance, whereby hunters are 
asked to submit heads from harvested animals for CWD testing (Figure 3).  
Component 1: Clinical surveillance via diagnostic pathology submissions 
(Diseased, dying, dead; ‘3D’)  
This is a convenience sample, with no specific sampling plan. Mule deer and 
white-tailed deer that are found dead, diseased or dying can be submitted any 
time of year to the Canadian Cooperative Wildlife Health Center for diagnostic 
pathology. These cases are acquired primarily through conservation officers, 
however hunters, farmers, biologists and members of the public submit a small 
proportion directly. Deer are more likely to be submitted in areas of increased 
human density, where they are more likely to be found. The decision to submit a 
sample for diagnosis is highly variable and depends on the judgment made by 
the conservation officers. Those deer with an apparent cause of death (eg. laying 
by the side of the road and therefore likely to have been hit by car) are less likely 
to be submitted than those with no obvious cause of disease or death. There is 
also a temporal variation in submissions; fewer carcasses are submitted in the 
summer and early fall compared to winter and spring for a variety of reasons 
(Chapter 3). The predominant reasons that conservation officers submit samples 
are: to determine cause of death, to diagnose disease agent, to determine 
wholesomeness of the carcass, and for forensic investigations. Once the 
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examination is complete, all results are entered and stored in the National 
Wildlife Disease (NWD) database housed within the CCWHC. The minimum data 
set within the NWD database consists of date submitted, name of submitter, 
location found, species, body condition score, age, sex, and gross pathological 
examination results. Other case information may be available such as history, 
date died, or results from advanced diagnostic examinations (histopathology, 
bacteriology, virology, parasitology, immunology, CWD testing) may be available 
on a case by case basis.  CWD testing is now (as of 2005) conducted on all 
clinical submissions aged 1 year or greater. The results from CWD testing are 
stored in a separate database (CWD database) with linkages to the NWD 
database.  
 
From 2000-2006, 4 positive deer were identified through this surveillance 
component. 
Component 2: Hunter-harvested CWD surveillance  
Hunters are required to submit the harvested heads through their local MOE 
regional office or designated drop-off location during and following the hunting 
season. In some areas, hunters may receive additional hunt tags after their initial 
deer heads are submitted. Received samples are tagged and demographic 
information (sex, age, location, date shot) is manually entered into a computer 
database. Location information is collected either descriptively (hunter describes 
where the deer was shot), or by a computer map, where the hunter simply points 
to the location on a computer screen and mapping coordinates are generated. In 
most cases, there is no information collected on the body condition of the animal, 
however if the animal is thin, the hunter will submit the entire carcass for post-
mortem examination (under 3D surveillance)  and a new tag will be issued. The 
information collected from the hunters is compiled and reviewed daily and then 
transferred electronically via an access database to the CCWHC, where it is 
integrated into the main CWD database.  All samples are kept frozen until they 
are transferred to the CCWHC for testing. Samples collected are heads including 
teeth (for age determination), brain, tonsils, and retropharyngeal lymph nodes 
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(RLN) which then are removed by the CCWHC for testing. Once the tissue 
samples are extracted, half the tissue is frozen and half is formalin-fixed. They 
are packaged, numbered to maintain identification and stored until testing. Initial 
IHC testing is done on tonsillar tissue by Prairie Diagnostic Services; six to a 
cassette. A positive tonsil sample will trigger further testing of the obex and RLN. 
This allows for confirmation and staging of the disease. Formalin-fixed tissue 
which tests negative is discarded.  All frozen samples (both positive and 
negative) have been retained in a tissue bank for future research purposes. Any 
samples which are not deemed to be testable (too autolyzed, or destroyed by 
gunshot) are discarded.  
  
From 1997 to 2004, testing was restricted to certain regions. Outside of those 
regions, hunters were charged $90 per head which dramatically affected sample 
submission rates in some areas. Since 2005, all harvested mule deer and white-
tailed deer over 1 year old are eligible for CWD testing at no charge to the 
hunter, regardless of sex or location of harvest. Samples are collected primarily 
in the winter months of November and December, coinciding with the legal 
hunting season. Sample size depends on geographic region (license allocations 
determined by the Ministry of Environment and based on CWD prevalence, deer 
density and other factors). Areas where CWD is known to exist will tend to have 
larger samples sizes because of management decisions to reduce herd 
densities.  
 
From 2000-2006, 145 positive deer were identified through this surveillance 
component. 
 
4.10 CANADIAN COOPERATIVE WILDLIFE HEALTH CENTER  
Data from hunter-harvest CWD surveillance is housed in the CWD database, 
while data from the clinical diagnostic specimens are housed in the National 
Wildlife Disease (NWD) database. A planning session was held in April 2007 to 
identify needs of data users, and to assist in directing improved functionality. As 
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a result, these databases were updated as of October 2007 and January 2008, 
respectively. One new application includes more drop-down menus which help to 
reduce data entry errors. There is currently no data dictionary available to users 
to standardize data entry. To date, no systematic review of data quality and data 
errors has been performed. These databases are backed up nightly. Access to 
these databases is limited and can be customized to the users needs (read only 
vs. full access). In general, raw data access is limited to CCWHC associates and 
to a limited number of researchers. Other requests for data are dealt with on a 
case-by-case basis. Data users must identify the intended use and sign an 
agreement for accountability, privacy and to protect intellectual property. The turn 
around time for a data request depends largely on the type of request made; 
these data are provided as an export file.  
RECOMMENDATION: Regular reviews of data quality (ie. Describing the 
proportion of missing fields and data entry errors) would help to further 
characterize where drop-down menus, standardized codes and other data entry 
tools would improve data quality. Development of a data dictionary would help to 
catalog the organization and contents of a database, including describing how 
data elements are encoded. This helps to establish consistency. 
4.11 CASE DEFINITION  
A confirmed case is defined as: 
A free-ranging mule deer (O. hemionus) or white-tailed deer (O. virginianus) with 
or without symptoms consistent with clinical CWD with one or more of the 
following tissues positive by immunohistochemistry: 
- tonsil 
- retropharyngeal lymph node  
- obex  
- any other lymphoidal or nervous tissue 
Test results are reported by species and by geographic region. There is no 
stratification based on pre-test probability of positive results.  
RECOMMENDATION: The case definition could be further expanded to 
incorporate the risk of being CWD positive and acknowledge the higher 
probability of disease in higher risk categories. Animals which exhibit symptoms 
consistent with CWD are more likely to test positive for CWD than animals 
without symptoms of CWD. Reporting results by risk profile will help to further 
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characterize any benefits of targeted testing. This could include the following 
case definitions: 
 
1) CWD SUSPECT - any animal greater than 1 year from any region in 
Saskatchewan observed to have been in poor or very poor body condition with 
accompanying clinical CWD signs (salivation, depression, increased or 
decreased flight zone, low head carriage, teeth grinding, unable to rise).   
2) ELEVATED CWD RISK - any animal greater than 1 year shot or found dead 
from any region in Saskatchewan and observed to be in poor or very poor body 
condition.  
 3) LOW CWD RISK- any animal greater than 1 year shot or found dead and 
observed to be in fair, good or very good body condition.  
These case definitions are based on previous observations and published 
literature. Thin animals exhibiting clinical signs of CWD have a higher probability 
of being infected (Miller, 2000). Animals with clinical disease are also assumed to 
be at higher risk for death due to motor vehicle collisions, gunshot wounds, 
predators, aspiration pneumonia and sudden death (Krum et al., 2005; Conner et 
al., 2000; Williams, 2005). 
4.12 OUTPUTS FROM THE SYTEM  
Provincial reports of surveillance results by species and wildlife management 
zone (WMZ) are generated along with a map of the spatial distribution of CWD 
positive cases in the wild. These summary reports are displayed on the CCWHC 
website (http://wildlife1.usask.ca/en/cwd/chronic_wasting_disease.php). The 
website is designed to continually upload new results from the database as they 
become available; this allows for real-time access to the most current summary 
report throughout the testing season. After testing is completed for the season, 
the results are reviewed and some data cleaning may occur. In this case, the 
website will adjust its’ results following the next upload. Other reports that are 
generated from this data are intermittent, but have included updates in the 
CCWHC newsletter, and surveillance and research updates for landowners and 
interested parties.   
RECOMMENDATION: Providing a statement on the iterative nature of the 
summary report will notify report users that results are subject to change. This 
could also include labeling of the summary report as either a draft or final 
summary. 
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4.13 CASE FOLLOW UP 
All positive CWD cases are reported to SMOE and to the Canadian Food 
Inspection Agency (CFIA). SMOE then notifies the submitter (hunter).  
Additionally, any hunter who submits a sample is able to receive his or her 
confidential results through a website application using their name and SMOE 
hunt tag #. The approximate turn around from time of submission to test results is 
7-8 weeks. All positive samples must be sent for confirmatory testing to the CFIA.  
4.14 OPERATING EXPENSES AND RESOURCES  
When CWD was first found, Saskatchewan Agriculture and Food paid for the 
testing in free-ranging populations. Since 2004, SMOE has provided the funding 
for testing. The funding is provided yearly as a lump sum and covers costs 
related to sample preparation and testing. CCWHC offers human resources to 
support the program, including veterinary pathologists, data managers, 
administrators, IT support, technicians, and provides training opportunities. 
CCWHC also offers material support such as computers and lab equipment.    
RECOMMENDATION: A cost-benefit analysis comparing the different 
surveillance components would assist program planning and ensure sound 
agency decisions based on benefits to the CWD program. 
 
4.15 PERFORMANCE EVALUATION OF THE SURVEILLANCE SYSTEM  
With the above stated objectives in mind, the most important attributes of this 
system are that it must be sensitive for early detection of disease and timely so 
that disease control action can be taken. Once CWD has been detected in a 
region, surveillance can be used to monitor trends over time and effectiveness of 
disease control efforts. It is then that the representativeness of the sample 
becomes important. Because both hunter-harvest and clinical surveillance 
components rely heavily on others to submit samples, it is also important that the 
surveillance system be simple and acceptable to users.  
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Sensitivity  
Surveillance sensitivity can be viewed in multiple ways. Most often, sensitivity 
involves estimating the proportion of the total number of CWD cases in the 
population under surveillance that are being detected by the surveillance system. 
Because many diseases, including CWD, cluster within a population, surveillance 
sensitivity could also be defined as an estimate of the proportion of positive 
clusters (or herds) under surveillance that are being detected by the system. 
Detection of CWD is very challenging due to its long latent period, subtle and 
somewhat non-specific clinical signs (eg. emaciation), and initially low within-herd 
prevalence; it causes a protracted epidemic in a population, often taking years to 
increase significantly in prevalence (Miller et al., 2000). Because the prevalence 
remains low for a considerable amount of time, detecting CWD early in an 
infected herd requires a very large sample to be confident that the disease is not 
present (or present below an acceptable level). For example, if there are 1000 
animals in the herd and the goal is to detect CWD at no higher than 0.5% 
prevalence (5 infected animals) using immunohistochemistry on tonsillar tissue 
(Se 99%; Spraker et al., 2002), at least 455 animals (46%) would need to be 
tested to be 95% confident that the herd did not have CWD at or above 0.5% 
prevalence (FreeCalc v2: 
http://www.ausvet.com.au/content.php?page=res_software ). This is neither 
feasible nor desirable in most situations for multitude of reasons. If the maximum 
acceptable prevalence is increased to 1%, a sample of 261 would be required 
and at 2% prevalence, a sample size of 140 would be needed. Even if a sufficient 
sample size is reached to detect a low prevalence of disease, this sampling 
would need to be repeated to account for the constant risk of introduction from 
surrounding infected areas or infected game farms. 
Because CWD clusters geographically, the total population should be thought of 
as multiple population units. Within these units, a minimum sample size would 
need to be tested to be confident that the disease is present below the maximum 
acceptable level. In Saskatchewan, as is the case in many jurisdictions, the 
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province is divided into administrative units or wildlife management zones 
(WMZ).  WMZs are the foundation for other geographic units, such as the MOE’s 
management units and ecozones and have been also used to derive population 
estimates, making them somewhat useful for spatial analysis.  One limitation of 
WMZs is that they do not necessarily correlate with biological population 
structures. Population estimates based on biologic population units would help to 
better interpret surveillance findings, however these estimates are currently not 
available.    
As an example of sensitivity, mule deer surveillance samples harvested from 
WMZs 1-14 from 1996-2006 were examined in order to demonstrate the 
challenges in achieving good sensitivity for detecting CWD. Population numbers 
were estimated by mule deer management units (MDMU) using mean winter 
population estimates (1984-2003) generated by Saskatchewan Ministry of 
Environment (Arsenault, 2005). The sample size required to detect CWD at 1% 
and 2% prevalence for each MDMU was calculated using Free calc v2 
(http://www.ausvet.com.au/content.php?page=res_software) and assuming test 
sensitivity of 99% (Spraker et al., 2002) (Table 1). Figure 4 depicts the actual 
number of hunter-harvest mule deer samples taken from these 7 MDMU from 
1997 to 2006; approximate minimum sample size required to detect CWD at 1% 
(n=295) and 2% (n=150) prevalence is also given.  
CWD was detected in two of these regions; 11-14 in 2002 and WMZ 8-10 in 
2006. CWD has not been detected in any other zones, however only zones 2 and 
4,5 have had intermittently high enough sample sizes to allow for conclusions 
about their disease status. Figure 4 also demonstrates the sampling bias towards 
zones where the disease has been found. This reflects the focus of this 
surveillance system on monitoring trends in infected areas, rather than disease 
detection.  
RECOMMENDATION: Reporting surveillance findings, both positive and 
negative, accounting for underlying population in each region, would help to 
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better demonstrate where surveillance efforts are adequate to detect disease and 
where more samples are required.    
One of the major challenges associated with the interpretation of these results is 
that the population estimates are based on administrative units, rather than 
biological units. This may lead to erroneous conclusions about the disease status 
of a population or adjacent populations. 
RECOMMENDATION: A better understanding of the population distribution 
within the province on a finer spatial scale, including understanding the 
interactions and movement between and within species would help to define 
biological population units. These population units would increase the validity of 
sensitivity calculations and estimates of disease freedom of a population. 
The value of target testing high risk animals has been recognized for some time. 
Animals with clinical disease (3D) have an increased probability of CWD infection 
and focused testing on this subset of the population will help to boost the 
sensitivity of the system. The challenge lies in the relative lack of methodology to 
analyze negative surveillance findings using non-random (targeted) sampling. 
Generally speaking however, if CWD were present in a population at 2% 
prevalence overall, the prevalence in the 3D population would be higher (see 
following section on sampling success) and the required number of animals to 
test to detect disease would be lower. Having recognized the value of target 
testing, there are many logistical barriers which often deter wildlife managers 
from pursuing this strategy. As a result, few samples are currently being 
submitted through this system and the current sensitivity of the clinical 
surveillance component is very low. Of the samples that are coming in, a number 
of them are coming from regions where CWD has already been detected. It 
follows that increasing submissions 3D cervids, particularly ‘CWD suspects’ and 
animals with ‘Elevated CWD risk’ from areas where CWD has not been detected 
will increase the sensitivity of the surveillance system. 
The sensitivity of the surveillance system components will be further explored 
using quantitative methods in a subsequent chapter.  
Sampling success 
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The sampling success is defined as the proportion of samples that actually have 
the health-related event (CWD) and can be used to describe the relative value of 
further categorizing samples by risk profile. In the case of the hunter-harvest 
surveillance, which involves somewhat random testing of healthy animals, 
145/28909= 0.0050 (0.5%) of samples were positive. With clinical surveillance 
4/263= 0.0152 (1.5%) of cases were positive (Table 2). 
If we instead stratify the deer tested by suspect case definition, elevated CWD 
risk and low CWD risk (hunter-harvest samples), the sampling success is 
increased dramatically in CWD suspects (Table 3).   
Timeliness 
There was very little difference reported in the timeliness of the two surveillance 
components (Table 4) and both components have acceptable timeliness. Overall, 
the time from submission to test results is usually around 3-4 weeks (up to 9 
weeks) assuming a maximum of 1 week from sample collection in the field to 
submission to the lab. Often with harvested animals, hunters will wait for results 
prior to consumption. Positive carcasses are then incinerated and a new tag will 
be issued if applicable.  
Because CWD is a slowly progressing disease, with a long incubation period 
seldom less than 18 months (Williams and Young, 1993; Williams, 2005), this 
surveillance system is considered by the author to be sufficiently timely for early 
detection of disease. 
RECOMMENDATION: The performance of this surveillance system as it 
pertained to timeliness was only evaluated for early disease detection. There are 
however, other factors that could have been considered when measuring 
timeliness of this system, including timeliness of reporting results to hunters and 
other stakeholders. A survey could be conducted to assess whether this system 
is sufficiently timely to meet stakeholder needs.   
Representativeness 
Representativeness is how well a surveillance system describes the occurrence 
of an event over time and its’ distribution in the population by place and person 
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(German et al., 2001).  In CWD surveillance, it is important once CWD has been 
detected in an area for estimating true prevalence and following trends over time. 
For monitoring trends over time, hunter-harvest surveillance has been used in 
many jurisdictions as the best available approach.  Although it is well understood 
that hunter-harvested samples have a propensity towards mature males and are 
not usually representative of the fawn and yearling population, in locations where 
CWD has been found, intensive herd reductions typically involve targeting of all 
age and sex categories. This results in a more representative sample. Hunter-
harvest sampling is very efficient is likely the most efficacious. Sharp-shooting 
has also been used in some jurisdictions and is reportedly even better at 
detecting cases and targeting all age groups; however this strategy often has 
very little public support making it more difficult to implement (Margo Pybus, 
personal communication). Clinical surveillance results should not be relied upon 
to estimate prevalence as they are biased and not representative of the 
population (Miller et al., 2000).  
This surveillance system would not be considered spatially representative, in that 
samples are clustered in certain geographic regions where CWD has been 
found, with relatively few samples coming from areas where the disease has not 
been detected, leaving the CWD status of these areas uncertain.   
Simplicity and Acceptability 
The simplicity and acceptability of the system was not formally evaluated, 
however some general comments can be made. The system is relatively simple; 
all samples are submitted though one wildlife authority agency who in turn 
submits the samples to one diagnostic lab for testing (Figure 3). Participation in 
the surveillance system is highly variable from region to region, and tends to 
improve following the discovery of a positive CWD deer. Testing is currently free 
for the hunter and individual confidential results can be retrieved easily online.  
In 2004, only samples from known positive areas were tested at no charge. 
Samples originating from outside of positive areas were tested at a charge of 
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$90. This caused a great deal of problems and submissions from “CWD- 
negative” areas dropped drastically. It was suspected that hunters were still 
harvesting from outside positive areas, but reporting that they originated within 
positive areas. This policy was quickly changed to the current situation, where all 
samples are tested at no charge.   
Prior to 1996, all pathology records were stored in paper hard copy, and 
therefore required manual record retrieval. All pathology submissions (both 
domestic and wild) were received through the same intake system and were 
catalogued in sequential order as they were received, making record retrieval 
cumbersome and time consuming. All location information was in descriptive 
format and required geo-coding for mapping, which was also very time 
consuming. Since 1996, a searchable electronic database has been created to 
store all the record information making data storage and use much simpler.  
Improvements in standardization of data entry are being made, and since 2005, 
location information has been much easier to collect via computer mapping.  
RECOMMENDATION: The surveillance system must be simple enough so that 
users of the system (SMOE, conservation officers, hunters) will submit as many 
samples as possible and provide the most complete information possible. There 
are a number of steps involved in the detection of a case. At each step, factors 
may impact whether a case is submitted or not. Methods for further improving the 
simplicity and acceptability of the surveillance system should be evaluated and 
barriers should be identified by consulting stakeholders to improve submission 
rates across all geographic regions.   
Data Quality 
Data quality speaks to the completeness and accuracy of the data recorded. 
Data quality of the clinical disease component has been discussed previously 
(Chapter 3) and overall the quality has greatly improved with time. Data quality of 
the hunter-harvest component is better than that of the clinical surveillance. 
There were 28909 hunter-harvested samples tested; only 123 (0.4%) were 
missing information on sex and 500 (1.7%) were missing age.  Point location 
information (latitude/longitude or UTM easting/northing) was missing in 14326 
cases (49.6%) but wildlife management zone information was only missing for 
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1719 cases (5.9%). Only 852 cases did not have any location information at all 
(0.3%). Therefore although the location information is reasonably complete, the 
spatial level to which the data can be analyzed is limited. Better point location 
information would allow for more fine spatial analysis.   
The clinical surveillance data was of lesser quality; with 61(14.9%) missing 
information on age and 160 (39.2%) missing information on sex. Point location 
information was missing for 308 (75.5%), while 23 (5.6%) submissions did not 
have location information at all.    
RECOMMENDATION: Having poor quality data is very expensive as it requires 
extensive cleaning, limits the extent to which it can be analyzed, and increases 
the chance of errors in interpretation. The value of collecting complete and 
accurate data needs to be emphasized to all involved in data collection. 
Increased use of drop down menus, required fields and entry restrictions help to 
prevent typographical errors and reduce the need for data cleaning. Data 
dictionaries and definitions also help to describe data components and would 
assist in standardizing data entry. Because CWD spatially clusters on a relatively 
small geographic scale, good quality point location information should be the 
goal. 
 
4.16 CONCLUSION 
Chronic wasting disease surveillance in Saskatchewan must serve two main 
purposes: 1) early detection of CWD at a low prevalence for rapid intervention 
and 2) to monitor spatial and temporal trends over time. The current surveillance 
system places more emphasis on monitoring trends, perhaps at the expense of 
early detection. This is explained mostly by the coupling of disease control efforts 
and surveillance, in that harvests are heavily focused in CWD-positive areas. 
Additionally, because it is not recommended to consume CWD infected meat 
there is an obligation to provide testing to this group. As a result, a very large 
number of hunter-harvest samples have been tested and the majority of positive 
cases have been detected through this component. 
In areas where the disease has not yet been detected and the prevalence is low, 
hunter-harvest surveillance is very inefficient at detecting disease. ‘Healthy 
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animals’ obtained through harvest have a very low probability of being infected 
and many more animals must be tested to detect disease. Alternatively, clinically 
ill animals, especially CWD suspects have a much higher probability of being 
infected and would therefore be a much more efficient way to detect CWD. 
Although this is true in theory, there are many challenges that impair the 
sensitivity of this system that must be overcome for it to be effective. The current 
clinical surveillance component is not sufficient to fill in the gaps and the primary 
reason for poor performance has been a very low submission rate. Enhancing 
this system in areas where the disease has not been detected would improve 
sensitivity. This will likely require additional resources for education and 
awareness campaigns and for front-line staff, but given the importance of 
managing this disease, would be money well spent.  
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Figure 1- Distribution of CWD in free-ranging and captive cervids in North 
America, as of January, 2009 
 
 
Source: http://www.nwhc.usgs.gov/images/cwd/cwd_map.jpg 
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Figure 2 - Locations of CWD positive wild deer (Odocoileus hemionus, 
Odocoileus virginianus, Cervus elaphus) in Saskatchewan 2000-2008 
 
Source: http://wildlife1.usask.ca/en/cwd/CWD_All_Positives_2000-2008.jpg 
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Figure 3- Dual component surveillance system for CWD in free-ranging 
mule and white-tailed deer in Saskatchewan (component 1- deer with 
clinical disease or dead (3D); component 2- hunter-harvested deer) 
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Surveillance results 
provided to stakeholders 
to guide program 
planning 
 
COMPONENT 2 
 
HUNTERS 
HARVEST AS PER 
LICENSE 
ALLOCATION  
Dissemination of 
surveillance 
findings 
Dissemination of 
surveillance 
findings 
 71 
Table 1 – Mule deer population estimates in 7 southwestern mule deer 
management units (MDMU) (Arsenault, 2005) and required sample size to 
detect CWD at 1% and 2% prevalence 
Prairie Grassland Ecozone 
Mule deer 
management unit 
(MDMU) 
Wildlife 
management 
zone (WMZ) 
Mean winter 
population 
(1984-2003) 
Sample size 
required to 
detect 1% 
prevalence 
Sample size 
required to 
detect 2% 
prevalence 
Big Muddy 1 1528 278 141 
Frenchman 2 3403 289 147 
Govenlock 3 1532 279 142 
Drainage 4,5 1509 275 137 
Cypress 6,7 3315 290 144 
G. Sandhills 8-10 8456 295 149 
S. Sask River 11-14 9620 297 146 
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Figure 4 - Mule deer samples harvested from wildlife management zones 
(WMZs) 1-14 by hunters from 1996-2006 with the minimum sample sizes 
required to detect disease from these areas at 1% (n=295) and 2% (n=150).   
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Table 2 – Sampling success of surveillance components 1 (clinical 
surveillance) and 2 (hunter surveillance) 
 Component 1:  
Clinical 
surveillance 
since 1997 
Component 2: 
Hunter 
surveillance 
since 1997 
 
Total 
# of positive cases detected 4 145 149 
# of negative cases  259 28764 29023 
Total # of cases tested 263 28909 29172 
Predictive value positive 0.0152 (1.5%) 0.0050 (0.5%)  
 
 
 
Table 3 – Sampling success using risk profiles (CWD suspects; Elevated 
CWD risk; Low CWD risk) 
 
 CWD 
suspects 
Elevated 
CWD risk 
Low 
CWD 
risk 
 
Total 
# of positive cases 
detected 
4 0 145 149 
# of negative cases  19 58 28946 29023 
Total # of cases tested 23 58 29091 29172 
Predictive value positive 0.174 
(17%) 
0 (0%)  0.0050 
(0.5%) 
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Table 4 - Time to detection of CWD in clinical or hunter-harvest surveillance 
components 
 
STEP 
 
EVENT 
Components 1 or 2: 
Clinical or hunter 
surveillance 
1 Animal is found sick or dead/ 
hunter harvests animal  
0 
2 Samples are collected 1day -1 week 
3 Samples are submitted 1-2 weeks 
4 Samples are tested 1-4 weeks 
5 Animal status reported 1-2 weeks 
 TOTAL TURNAROUND TIME 3- 9 weeks 
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5. A QUANTITATIVE EVALUATION OF CWD SURVEILLANCE IN FREE-
RANGING DEER IN SASKATCHEWAN; 1997-2006 
 
5.1 ABSTRACT 
A quantitative evaluation of a surveillance system for Chronic Wasting Disease 
(CWD) in free-ranging mule (Odocoileus hemionus) and white-tailed deer 
(Odocoileus virginianus) was conducted to evaluate surveillance system 
sensitivity and probability of disease freedom in the south-east part of 
Saskatchewan where CWD has not yet been discovered in wild populations. A 
scenario tree model was developed to incorporate target testing of animals with 
clinical signs of CWD along with hunter-harvested samples. A total of 120 
clinically ill animals from the passive surveillance system and 2112 hunter 
harvested animals in 25 wildlife management zones (WMZs) from 1997-2006 
were included in the analysis. Using this methodology, efficacy of the two 
surveillance system components was also evaluated. The overall mean 
sensitivity of both CWD surveillance components (SSc_hunter and SSc_3D) was 
poor from 1997 to 1999, increased dramatically from 2000 to 2003, and then 
declined to lower levels in 2004. Sensitivity results largely depended on the 
number of samples submitted and the design prevalence used in the modeling 
scenario. Low prevalence situations where it was desired to find one infected 
WMZ at 1% prevalence resulted in low sensitivity (22.7%; 95%CL:19%-26.4%; 
2001) as compared to higher prevalence situations where it was desired to find 
two infected WMZs at 5% prevalence (79.4%; 95%CL: 75.8%-83.5%). 
Confidence of disease freedom was dependent on the ongoing risk of disease 
introduction. Based on surveillance findings, if the risk of introduction from 1997-
2006 was low (0.01), the probability that CWD was present in at least 2 WMZs at 
5% prevalence or greater was negligible. Finally, the relative value of testing 75 
animals from the different surveillance components was compared to quantify the 
gain in sensitivity from target testing high risk CWD suspects. The sensitivity ratio 
was highest (12. 537) under low prevalence scenarios (1 infected WMZ at 1% 
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prevalence), meaning in low disease prevalence situations there is much to be 
gained by using targeted surveillance.  
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5.2 INTRODUCTION 
Chronic wasting disease was first detected in Saskatchewan in 1996 in a game-
farmed elk (Kahn et. al, 2004). It was later found in wild mule deer (Odocoileus 
hemionus) (CCWHC, 2001), farmed and wild white-tailed deer (Odocoileus 
virginianus) (Kahn et. al., 2004; CCWHC, 2003) and was recently identified in 
wild elk (Cervus elaphus) (CCWHC, 2008).  A map detailing the current known 
distribution of CWD in wild deer populations in Saskatchewan is given in Figure 
1. Objectives for managing CWD in wild cervids, as outlined by Canada’s 
National Chronic Wasting Disease Control Strategy (2005), include: 1) preventing 
further emergence 2) early detection and 3) effective management. 
 
In Saskatchewan, surveillance for CWD in wild deer relies on hunter-harvest 
submissions, which primarily target healthy animals. Hunter-harvested animals 
are commonly used due to the relative ease in collecting large numbers of 
samples at a reduced cost. The sampling frame is not random; hunting is used 
as a means to manage populations and certain sex and age groups are more 
heavily harvested relative to others. The sampling rate and intensity is also 
spatially heterogenous; sampling is largely tied to disease control and as a result, 
more samples are collected from regions where CWD has been previously 
discovered. In addition to hunter submissions, conservation offices or members 
of the public also submit diseased, dying or dead cervids (3D surveillance) for 
testing, including those that are exhibiting signs consistent with CWD (poor body 
condition with accompanying neurologic signs such as salivation, depression, 
increased or decreased flight zone, low head carriage, hyper-excitability, teeth 
grinding or unable to rise) (Williams, 2005). This population of clinically diseased 
animals is considered to be a high risk group, in that the probability of being 
CWD positive is much higher. Focusing on this subpopulation would be 
considered targeted or risk-based surveillance.   
 
Surveillance for CWD is currently being conducted in both ‘positive areas’ where 
the disease has been previously identified and ‘negative areas’ where the 
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disease has not been identified. In areas where CWD has been found, the 
primary objective of surveillance is to estimate prevalence and monitor trends 
over time. Alternatively, in areas where CWD has not been found, early disease 
detection is the primary objective. When analyzing surveillance results from 
‘negative’ regions, there are two possible scenarios to consider; negative 
surveillance could mean that the population is truly free from disease, or 
alternatively, that the disease is present in the population at some level but the 
surveillance system did not detect it. It is important to distinguish between these 
two scenarios.  
 
The CWD strategy in Canada states that effective control hinges on early 
detection, and that the goal is to detect infected populations at no higher than 
0.5-1% prevalence.  At such a low prevalence, detection is extremely resource 
intensive; large numbers of randomly selected animals must be tested in order to 
detect infection, or alternatively to declare the population ‘disease-free’ with a 
certain degree of confidence (eg. 95% confident that CWD is below 1% 
prevalence).  In the face of limited resources, risk-based testing strategies are a 
good alternative to large random samples. Risk-based testing (such as the ‘3D’ 
surveillance) can be more efficient in detecting disease in that it targets animals 
(or populations) at increased risk of being infected (this subpopulation has a 
higher prevalence of disease). Similar to BSE, clinical “CWD-suspects” (greater 
than 1.5 years in poor body condition showing neurologic symptoms) have a 
higher prevalence of disease than the general population (Miller et. al., 2000). 
Additionally, these animals, through their altered mental status are more likely to 
get hit by a vehicle (Krumm et. al., 2005), killed by a predator (Williams, 2005), or 
to venture into farmyards (Trent Bollinger, personal communication). The 
challenge in using this non-random approach has been in the lack of 
methodology available to interpret negative findings (Samuel, 2003).   
 
Quantitative methods have been developed to calculate disease freedom 
estimates using data derived from large random surveys; however few have 
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developed methodology that can incorporate multiple sources of disparate 
information, including information generated from non-random surveillance. 
Hueston and Yoe (1999) proposed using scenario trees to model surveillance 
systems to do power and sensitivity calculations.  More recently, Cannon (2002) 
and Martin et al. (2007) presented methodology which allows for combining of 
multiple surveillance sources, including targeted surveillance programs to 
calculate sensitivity of surveillance systems and estimate the probability of 
disease freedom. Although this methodology has been used primarily in 
substantiating disease freedom claims for trade of domestic livestock, it was 
hypothesized that this technique could be extrapolated for use in other areas, 
such as CWD surveillance in free-ranging deer. Therefore, the objectives of this 
study were to apply methodology previously presented by Martin et al. (2007) to 
do the following: 1) To calculate the total mean sensitivity of the two CWD 
surveillance components in Saskatchewan (‘hunter-harvest’ and ‘clinical’ or 3D 
surveillance) in a ‘CWD-negative’ area from 1997-2006; 2) To estimate the 
probability of disease freedom in this area; and 3) To compare efficacy of the two 
CWD-surveillance system components.  
 
5.3 METHODS 
It is impossible to state that a population is absolutely disease-free without 
testing the entire population simultaneously with a perfect test.  Rather, this 
methodology aims to determine probability of disease freedom given the 
sensitivity of the surveillance system at a pre-determined prevalence, or 
threshold prevalence (maximum acceptable prevalence) (Martin et al., 2007). 
Just like a diagnostic test, the sensitivity of a surveillance system is the 
probability that it will give a positive surveillance outcome, given that the 
population is truly infected (Pr (T+¦ D+)). Surveillance system sensitivity is 
dependant on the prevalence of the event of interest (CWD infection). Intuitively, 
if the prevalence of a disease is very high, fewer animals will need to be tested to 
detect the disease. Alternatively, with very low prevalence, many more animals 
would need to be tested to detect the disease. The threshold prevalence is often 
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determined by what is considered expected or acceptable. A commonly stated 
‘maximum acceptable prevalence’ for CWD is 0.5-1%, meaning that the goal is to 
detect CWD in a population at 0.5-1% prevalence or lower (Bollinger et al., 
2004).  
 
This method uses stochastic scenario tree modeling to estimate sensitivity using 
multiple data sources, including non-random sampling. There are two primary 
assumptions: 1) all final results from the surveillance system are negative and 2) 
the specificity of the surveillance system is 100%, that is all results will be 
confirmed positive (distinguishing between false positives) (Martin et al., 2007). A 
scenario tree is developed to represent all the possible pathways from the 
starting point (population is infected) to the outcome (infection is detected or not) 
and to divide the surveillance population into groups which have the same 
probability of being diseased, given the population is infected. Groups are 
distinguished by factors which affect either their probability of being infected or of 
being detected. Each branch of the tree is assigned probabilities for each 
outcome, which helps to capture variable risk within a population. The 
surveillance sensitivity is then calculated by multiplying the probabilities down 
each limb of the tree and summing those with positive outcomes (Martin et al., 
2007). 
 
If all surveillance results are negative, the probability of disease freedom can be 
estimated ie. What is the probability the region is free from CWD, given the 
surveillance system failed to find the disease, or Pr(D-|T-)? In other words, this is 
the negative predictive value which can be calculated using Bayes theorem, 
using the surveillance system sensitivity and a prior probability of disease 
freedom (Martin et al., 2007). The prior probability is a function of the previous 
surveillance evidence accumulated over time and the ongoing risk of 
introduction.   
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SCOPE OF THE MODEL 
The sensitivity of Saskatchewan’s CWD surveillance system in free-ranging mule 
and white-tailed deer was calculated using methods previously described by 
Martin et al. (2007). A scenario tree model was developed to depict the 
surveillance system. In order to estimate disease freedom, surveillance results 
from the south eastern part of the province were analyzed because CWD has not 
been found in free-ranging populations. For this analysis, actual animal 
surveillance results from 1997 to 2006 were used from Wildlife Management 
Zones (WMZs) 1, 15-18, 20, 21, 31-42, 48, 49, 56-59 (Figure 2). 
 
CWD SURVEILLANCE SYSTEM COMPONENTS 
The surveillance system (SS) for CWD in Saskatchewan has two surveillance 
system components (SSc); a surveillance component consisting of submissions 
of clinically ill animals (diseased, dying, dead) (SSc_3D) and a surveillance 
component consisting of submissions from hunter-killed animals (SSc_hunter). 
Samples from both components are submitted along with information on species, 
age, sex, and geographic location. Location information includes point locations 
when available (latitude, longitude); surveillance results are further aggregated 
into wildlife management zones (WMZ).  All samples were tested via 
immunohistochemistry (Spraker et al., 2002). All results in these WMZs from 
1997-2006 were negative. 
 
1) Clinically ill animals – Diseased, dying, dead submissions (SSc_3D) 
Samples from clinically ill or dead animals were collected and submitted for 
pathologic diagnosis primarily through conservation officers. Concerned 
citizens could call their local Saskatchewan Ministry of the Environment office 
to report a sick animal. A conservation officer would then attend the site, 
euthanize the animal (if required) and submit the carcass (or portions thereof) 
to the Canadian Cooperative Wildlife Health Center (CCWHC) for necropsy. 
Samples were submitted primarily to determine cause of death, for food safety 
disposition, or for forensic investigations. For the purposes of this analysis, 
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animals from the SSc_3D were further categorized by assessed CWD risk: 1) 
CWD Suspect- found alive in poor or very poor body condition exhibiting 
neurologic symptoms such as salivation, depression, increased or decreased 
flight zone, low head carriage, hyper-excitability, teeth grinding or unable to 
rise, 2) Elevated CWD Risk- found alive in poor body condition, and not 
exhibiting neurological symptoms or dead in poor or very poor body condition 
and 3) Low CWD Risk- found dead or alive (and euthanized) in fair, good or 
very good body condition. Any case missing information on body condition 
was placed into the Low CWD risk category for the purposes of this analysis. 
From 1997-2006, a total of 120 samples were tested in these 24 WMZs. The 
distribution of these samples by WMZ is given in Figure 3 and the yearly 
number of samples is given in Table 1. 
 
2) Hunter-harvested submissions (SSc_hunter) 
Hunter-harvested surveillance was initiated in 1997, following the discovery of 
CWD in a farmed elk herd. From 1997-2006, a total of 2112 samples have 
been tested from these 25 WMZs. The distribution of these samples by WMZ 
is given in Figure 4. Hunter-harvested samples submitted for CWD testing 
were primarily adult deer because they have a higher probability of being 
infected. The number of samples submitted each year is given in Table 2. 
Heads (including brain, retropharyngeal lymph nodes, and tonsils) from 
hunter-harvested animals were submitted via hunters to the local Ministry of 
the Environment office. Samples were then sent to the CCWHC which 
conducted the testing (with Prairie Diagnostic Laboratories) and reported 
results.  For the purposes of this analysis, all hunter-harvested animals are 
assumed to be healthy and in good body condition because if after an animal 
is shot, it is found to be in poor body condition or have significant disease, it 
will be submitted through the SSc_3D.  Therefore, all animals submitted 
through the hunter-harvest program are considered ‘Low CWD Risk’ based on 
the risk categories defined previously. 
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DATA SOURCES 
1) Canadian Cooperative Wildlife Health Centre (CCWHC) 
Records of all wild white-tailed deer and mule deer samples submitted to 
the CCWHC were examined. This included diseased animals submitted by 
conservation officers, and those submitted through the hunter-harvested 
CWD program. Information obtained from these records included species, 
history, age, sex, location, body condition, necropsy and histology results. 
 
2) Saskatchewan Ministry of the Environment   
The Saskatchewan Ministry of the Environment provided information on 
population estimates and geographic distribution of both mule and white-
tailed deer.  
 
3) CWD Literature 
Published literature was used to model the sensitivity of 
immunohistochemistry and relative risk differences of target testing. 
 
4) Expert opinion/Author 
Expert opinion or the opinion of the author was used when data were not 
available for the model. 
 
SCENARIO TREE 
A simplified scenario tree was developed to model the surveillance system using 
the technique described by Martin et al. (2007) and the sensitivity of the 
surveillance system at a pre-set prevalence (design prevalence) was calculated. 
Surveillance results from white-tailed deer and mule deer were analyzed 
together. Groups with equivalent risk of disease represent individual limbs in the 
tree. For example, some groups, such as clinical suspects greater than 1 year, 
have a higher probability of being diseased, when compared to normal, healthy 
animals greater than 1 year. The nodes of the scenario tree are described in 
Table 3 and the scenario tree describing the surveillance system is given in 
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Figure 5. Each node is conditional on all higher nodes. The unit of analysis was 
the individual animal. 
 
 
MODEL INPUTS 
 
Risk parameters for branch probabilities were estimated and modeled using 
distributions (Pert and Uniform) in order to account for uncertainty using 
stochastic modeling. Model inputs are described in more detail below and 
summarized in Table 4.  
 
Region 
Region was considered a risk factor for this analysis. CWD is transmitted 
horizontally from an infected animal (Miller and Williams, 2003) or through 
exposure to infected environments (Miller et al., 2004). It follows that free-ranging 
animals in close proximity to areas where CWD is known to exist (in the wild or 
on game farms) are at higher risk of infection. The increase in surveillance 
sensitivity gained by targeting higher risk areas is a function of 1) the proportion 
sampled from those regions and 2) the relative risk difference of infection 
between areas of higher and lower risk (Martin et al., 2007).  For this analysis, 
WMZs were divided into either the HighRisk branch or the Other. Only proximity 
to known infected wild cervids was considered, therefore WMZs 42, 49, 58, and 
59 were considered to be at higher risk because these zones were adjacent to 
known positive WMZs. The relative risk (RR) of a HighRisk WMZ being infected 
relative to Other was modeled conservatively via a Pert distribution [Pert (1, 2, 
3)]. The RR was then adjusted by the underlying estimated proportion of deer in 
the HighRisk and Other regions to ensure that the weighted average adjusted 
risk across the limb was 1. The proportion of the population of deer in those 
WMZs was determined by dividing the number of estimated deer coming from 
WMZs 42, 29, 58 and 59 by the total number of estimated deer from all WMZs in 
the study area (Arsenault, 2005). 
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WMZ status 
Within the study region, a WMZ would either be infected or uninfected. The WMZ 
design prevalence or ‘threshold prevalence’ (P*H) defines the prevalence 
assumptions for which the sensitivity is valid and are not subject to uncertainty 
(Martin et al., 2007). For this study, sensitivity was calculated under two P*H 
scenarios: 0.04 and 0.08. This is equivalent to 1 or 2 WMZs infected of the 25 
WMZs, respectively.  
 
Age 
Young animals have a much lower probability of disease, and therefore testing of 
young animals is of less value than testing animals greater than 1.5 years of age. 
For this analysis, samples were divided into two categories: <1 year (Juvenile) 
and = 1 year (Adult), based on the quality of age information available. The risk 
of Adult being infected relative to Juvenile was modeled conservatively via a pert 
distribution [Pert (10,15,20)]. The underlying population structure was estimated 
using SMOE’s Cooperative Deer Management Survey (CDMS) (Arsenault, 
2005).    
 
Health status 
Animals were divided into three risk categories:   1) A CWD Suspect was defined 
as any animal observed to have been in poor or very poor body condition with 
accompanying neurologic signs (salivation, depression, increased or decreased 
flight zone, low head carriage, teeth grinding, unable to rise) potentially 
consistent with CWD; 2) An animal with Elevated CWD Risk was any other 
animal observed to be in poor or very poor body condition. Animals with clinical 
disease are assumed to be at higher risk for death due to motor vehicle 
collisions, gunshot wounds, predators, aspiration pneumonia and sudden death; 
3) An animal with Low CWD Risk was any animal found dead and observed to be 
in fair, good or very good body condition. CWD suspects and those with Elevated 
CWD Risk have a higher risk of infection relative to those with Low CWD Risk. 
The risk of CWD suspects and Elevated CWD Risk was modeled using uniform 
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distributions (13.2, 25) and (3, 13) relative to Low CWD Risk. These estimates 
were derived from the literature (Miller et al., 2000; Krumm et al., 2005) and 
using actual Saskatchewan surveillance results in areas where CWD has been 
identified. The proportions of animals which die each year that are CWD 
Suspects, Elevated CWD Risk and Low CWD Risk were estimated using 
historical unpublished data from the Saskatchewan wildlife passive surveillance 
system.  
 
Animal status 
The threshold prevalence or design prevalence at the individual animal level 
(P*U) is defined as the probability that an individual animal is infected, given 
that the herd is infected. For this analysis, values of 0.01, 0.02, and 0.05 (1%, 
2% and 5% prevalence) were used to demonstrate the fluctuation in sensitivity 
and disease freedom results depending on surveillance goals. 
 
Test positive 
The probability of a sample testing positive is dependant on the sensitivity of 
the diagnostic test, in this case immunohistochemistry (IHC). The specificity of 
this test was assumed to be 100%, as all positive samples are sent for 
confirmatory testing. For this analysis, the sensitivity was modeled 
conservatively using a Pert distribution (0.906, 0.973, 0.997) (Miller et al., 
2002). 
 
Confirmed positive 
This input describes the probability that a test positive sample will be 
confirmed positive. For the purposes of this analysis and to maintain simplicity 
of the model, it was assumed that all samples that were initially test positive 
were confirmed positive with a perfect test (Se 100%, Sp 100%).     
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SSC SENSITIVITY CALCULATION 
Surveillance results were analyzed yearly rather than monthly because CWD is a 
slow spreading disease with a relatively long duration of clinical disease. The 
sensitivity of the surveillance system was calculated for each WMZ using the 
binomial probability formula (Martin et al., 2007, Eq. 8). The ‘WMZ sensitivity’ is 
the probability that at least one animal will test positive after testing n animals if 
the WMZ is infected at prevalence P*U (Martin et al., 2007). The overall 
surveillance system sensitivity was calculated using SSc_3D and SSc_hunter for 
each year from 1997-2006. The overall sensitivity is the probability that at least 
one WMZ will test positive when infection is present at a pre-determined design 
prevalence or Pr (T+¦ D+).  
 
STOCHASTIC SIMULATION 
Monte Carlo stochastic simulation of results was conducted using PopTools 
2.7.5. (Hood, 2006). A fixed random number seed of 1 was used with 3000 
iterations. Uncertainty around region, age, health status and IHC sensitivity was 
modeled using the distributions previously described.  
 
PROBABILITY OF CWD FREEDOM   
The probability of the region being free of disease given our surveillance results, 
or Pr (D-¦ T-), was modeled each year using Bayes theorem. The posterior 
probability of disease freedom is a function of the prior probability of disease 
freedom and the sensitivity of the surveillance system. The prior probability of 
being free was set at 0.676, based on the prevalence among the other 37 WMZs 
in the western part of the province (12/37 or 32.4%). Because the risk of 
introduction is ongoing and needed to be accounted for, the posterior probability 
of disease from the previous year was discounted by the probability of 
introduction to obtain the new prior probability of disease (Martin et al. 2007, Eq. 
18). There was no information available to model the probability of introduction, 
therefore low risk (0.01) and high risk scenarios (0.1) were used.  
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SENSITIVITY RATIO 
A sensitivity ratio was calculated to compare the sensitivity of SSc_3D with 
SSc_hunter in order to help describe the benefit of targeted testing of high risk 
animals. The sensitivity of each component was simulated using hypothetical 
data and the components were compared. Hypothetical data consisted of 3 
animals tested per WMZ (n=75) in each of the SSc_hunter and SSc_3D (CWD 
suspect). 
 
5.4 RESULTS 
 
SURVEILLANCE SENSITIVITY CALCULATION 
The overall mean sensitivity of both CWD surveillance components (SSc_hunter 
with SSc_3D) combined from 1997 to 2006 in the CWD-negative area under the 
six design prevalence scenarios (previously described) is presented in Figure 6 
and Table 5. Surveillance sensitivity was poor from 1997 to 1999 and increased 
dramatically from 2000 to 2003, reflecting increased intensity of hunter-harvested 
surveillance during that time. Although the largest number of clinical samples in 
one year was submitted in 1997 (n=40), the sensitivity remained low given the 
nature of the samples; greater than half were in young animals (n=21), and the 
majority of adult animals were in good body condition (n=13). Sensitivity results 
were largely dependent on the design prevalence, with as much as a mean 
difference of 56.7% in the peak year, 2001 between the most conservative 
Scenario 1 (1/25 WMZs infected at 1% prevalence) and the least conservative 
Scenario 6 (2/25 WMZs infected at 5% prevalence). 
 
PROBABILITY OF DISEASE FREEDOM 
 
The probability of the eastern part of the province being free of disease given our 
surveillance results, or Pr (D-¦ T-), is given in Figure 7 and Table 6. Scenario 
1(1/25 WMZs infected at 1% prevalence) and Scenario 6 (2/25 WMZs infected at 
5% prevalence) were modeled using low and high risk probability of introduction 
scenarios (0.01 and 0.1, respectively). Results clearly demonstrate the need for 
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increased vigilance and surveillance intensity as the risk of introduction 
increases. Alternatively, if the risk of disease introduction is low, confidence of 
disease freedom increases over time as surveillance results accumulate. Based 
on surveillance findings, if the risk of introduction from 1997-2006 was very low 
(0.01; ie. disease is introduced once in 100 years), the probability that CWD was 
present in at least 2 WMZs at 5% prevalence or greater is negligible.     
 
SENSITIVITY RATIO 
The sensitivity ratio is a measure of the performance of the SSc_3D relative to 
SSc_hunter. Results from the hypothetical data comparing the two components 
SSc_hunter with SSc_3D under the six different scenarios are presented in Table 
7. Comparing the relative value of testing 75 CWD suspects to 75 hunter-
harvested animals, we see that as the prevalence increases, the relative value of 
testing clinical animals’ decreases.  
 
5.5 DISCUSSION 
 
The intent of this analysis was not to make definitive claims regarding the status 
of CWD in wild deer in eastern Saskatchewan, but rather to demonstrate the 
potential of using this quantitative methodology in order to calculate CWD 
surveillance system sensitivity, probability of disease freedom and to quantify the 
gain in sensitivity using targeted surveillance in wild deer.  
 
It is clear from this analysis that the overall sensitivity of a surveillance system is 
highly dependent on what the surveillance goals are; the lower the prevalence 
you wish to detect, the higher the surveillance intensity required. Although this 
typically means an increased number of samples are required, this can be 
augmented with targeted strategies, such as was demonstrated by targeting 
CWD suspects. Although the overall number of CWD suspects that were 
examined using the 3D surveillance system was low during this time period, the 
sensitivity ratio demonstrates that testing more of these suspects would help 
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boost sensitivity dramatically in areas of low prevalence and ultimately improve 
confidence of disease status.  
 
Additionally, this analysis demonstrates the susceptibility of disease freedom 
confidence in situations where there is an ongoing high risk of disease 
introduction. Risk of disease introduction can increase slowly over time from 
migration of animals from positive CWD areas or increase dramatically via 
intentional movement of infected animals into disease free areas. For this 
reason, ongoing risk must be continually assessed and used to adjust 
surveillance system goals. Close collaboration and cooperation between 
provincial agricultural (game–farming industry) and wildlife organizations is 
essential. 
 
One of the main challenges in using quantitative methodologies is that they often 
work best in situations were ample data exist to obtain good estimates for model 
inputs. This presents a significant challenge in wildlife disease scenarios for two 
reasons; 1) wildlife populations are inherently more diverse and difficult to study 
than domestic populations due to their elusiveness and large geographic 
distribution making it more difficult to acquire accurate estimates for modeling; 
and 2) wildlife management and research receives less funding overall than 
research used to support agricultural industry and trade. Ultimately, the 
usefulness of these methods in wildlife situations will depend on obtaining an 
overall better understanding of the distribution and dynamics of diseases in 
wildlife populations. In this case, the model would benefit from more accurate 
population estimates and better estimates of the risk of CWD introduction in 
different scenarios (natural movement or migration of infected animals or 
spillover from positive game farms). Finally, identifying and incorporating other 
herd and animal level risk factors for CWD (eg. sex, density, artificial baiting, etc.) 
would help to further refine the model.  
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This quantitative methodology would be useful in developing surveillance 
strategies for disease detection at the regional level. In each ‘negative region’, a 
cost-benefit analysis could be conducted to determine the most economic way to 
meet surveillance objectives. That is, would it be more beneficial to increase the 
number of harvested samples through increased tags, incentives, etc. as 
compared to running campaigns asking people to report injured animals, and 
picking up road kill? Obviously, in areas where the human population density is 
low, public relations campaigns and relying on 3D passive surveillance systems 
to achieve surveillance goals may be unrealistic. On the other hand, in highly 
populated areas, surveillance goals may be easily met through improving the 
number of 3D passive surveillance submissions. A point system, similar to that 
developed by the OIE for BSE surveillance 
(http://www.oie.int/eng/normes/mcode/en_chapitre_1.11.6.htm), could be 
developed, making it more user-friendly and comprehensible for conservation 
officers and managers to meet local surveillance system goals.  
 
There are many limitations worth mentioning. Ultimately, the model could have 
been made more complex and more risk nodes could have been included in the 
model. However because the intent of this analysis was to demonstrate the 
potential of this methodology under different scenarios, and data were sparse to 
non-existent in many situations, simplicity was maintained at the expense of 
limiting the model. A significant limitation of this model is the lack accurate 
population and local mortality estimates, and incomplete information on the risk 
differences between high risk and low risk regions. The use of wildlife 
management zones (WMZs) as a surrogate measure for a herd or population unit 
also limits the use of this model, however there were no other alternatives to 
represent biological clustering of CWD. Additionally, deer population density of 
the different regions was not included in the model even though it may also be 
considered a risk factor for disease spread. Density was excluded because data 
were not available for the differential risk difference between high density and low 
density situations. Both white-tailed deer and mule deer samples were treated 
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the same, even though there are many differences between the two species (eg. 
they occupy different habitats, are at different densities in difference regions, and 
would have different contact rates within and between species). Although elk are 
susceptible to CWD, they were not included in this model to preserve simplicity. 
Finally, the risk from game farm animals was not incorporated into the model, as 
data were not available.  
 
Although the model was simplified and didn’t include different risk nodes like sex, 
and density, including these risk factors would likely not have affected the model 
outputs substantially, especially with the SSc_3D surveillance component, due to 
the overall low number of submissions to the surveillance system. These factors 
would be more important as the number of submissions increases and should be 
considered for future models.  
 
 
5.6 CONCLUSION 
The methodology, as outlined by Martin et al. (2007), has been shown to be 
useful for estimating surveillance sensitivity, probability of disease freedom and 
to demonstrate the benefit of risk-based target testing.  Further, it can and should 
be used as part of the surveillance evaluation process in order to measure if 
surveillance systems are meeting surveillance objectives and to demonstrate 
where surveillance is adequate and where it is not. Ample, good quality data are 
required to improve the application and robustness of these models in wildlife 
scenarios.  
 
Based on this analysis, surveillance in the eastern part of Saskatchewan is not 
adequate to detect CWD at 0.5-1% prevalence. Having said that, this area has 
not been a focus of surveillance and even with the limited surveillance that has 
been done, it can be concluded that if the risk of disease introduction was very 
low, the prevalence is not 5% or higher. The use of more targeted surveillance 
strategies should be further explored to help better meet surveillance objectives.  
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Figure 1. Locations where chronic wasting disease has been detected in 
wild deer in Saskatchewan; 2000-2008 
Source: http://wildlife1.usask.ca/en/cwd/chronic_wasting_disease.php 
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Figure 2 - Map of area showing the eastern Saskatchewan WMZ that were 
included in this analysis (1, 15-18, 20, 21, 31-42, 48, 49, 56-59) 
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Figure 3 – Number of 3D clinical samples submitted from wild mule and 
white-tailed deer in eastern WMZs (1, 15-18, 20, 21, 31-42, 48, 49, 56-59)*; 
1997-2006  
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* n=0 samples submitted in zones 20, 32, 56, 57, 58, 59 
 
 
Table 1 – Yearly number of clinical samples submitted from wild mule and 
white-tailed deer in eastern WMZs (1997-2006)  
 
Year Number of 
samples 
submitted 
1997 40 
1998 3 
1999 5 
2000 6 
2001 25 
2002 7 
2003 5 
2004 11 
2005 11 
2006 7 
TOTAL 120 
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Figure 4 – Number of hunter-harvested samples (mule and white-tailed 
deer) submitted from eastern WMZs (1, 15-18, 20, 21, 31-42, 48, 49, 56-59) 
from 1997-2006  
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Table 2 – Yearly number of hunter-harvested samples from wild mule and 
white-tailed deer in eastern WMZs, submitted for testing through the 
SSc_Hunter surveillance component from 1997-2006 
 
Year Number of 
samples 
1997 16 
1998 7 
1999 22 
2000 182 
2001 570 
2002 643 
2003 493 
2004 5 
2005 83 
2006 91 
TOTAL 2112 
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Table 3 - Infection, detection and risk category nodes in the scenario tree 
modeling CWD surveillance in wild mule and white-tailed deer, including 
potential outcomes at each node 
 
 
 
Node 
 
 
 
Name 
 
 
Type of Node 
 
 
Outcomes 
 
 
Next 
Node 
 
1 Region Risk category - High risk - Other 
2 
2 
2 WMZ infected Infection - Infected 
- Not infected 
3 
End 
3 Age Risk category - Adult (=1 yr) - Juvenile (<1yr) 
4 
4 
4 Health status Risk category 
- CWD suspect1 
- Elevated CWD risk 
- Low CWD risk (other) 
5 
5 
5 
5 Animal infected Infection node - Infected 
- Not infected 
6 
End 
6 Test positive Detection - Yes - No 
7 
End 
7 Confirmed positive Detection - Yes - No 
End 
End 
1 Clinical suspect- poor body condition with accompanying neurologic signs such as salivation, 
depression, increased or decreased flight zone, low head carriage, teeth grinding or unable to 
rise 
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Table 4 – Parameter estimates used in the scenario tree model for 
surveillance of chronic wasting disease in Saskatchewan 
 
Parameter 
Point estimate or  
distribution of 
value  
Source 
Region 
    RR in a region adjacent to a  
    CWD  positive area  
    (HighRisk) relative to Other 
    
    Proportion of deer in 
    HighRisk area      
 
Pert (1,2,3) 
 
 
 
0.122 
 
Author 
 
 
 
Arsenault, 2005  
P*H 
    1 of 25 WMZs infected 
    2 of 25 WMZs infected  
 
0.04 
0.08 
 
Author 
Age 
    RR Adult : Juvenile 
 
    Proportion of adults  
 
Pert (10,15,20) 
 
0.618 
 
Author 
 
Arsenault, 2005 
Health status 
    RR CWD Suspect 
    RR Elevated CWD Risk 
 
    Proportion CWD Suspect 
    Proportion Elevated Risk 
    Proportion of Low Risk 
 
Uniform (13.2, 25) 
Uniform (3,13) 
 
0.022 
0.353 
0.625 
 
Miller et al, 2000; unpbl. SK data,  
Krumm et al, 2005; Author 
 
Unpbl. SK data 
P*U 
    1% prevalence 
    2% prevalence 
    5% prevalence 
 
0.01 
0.02 
0.05 
 
Author 
Test positive 
        Pr (T+|D+) 
 
Pert (0.91, 0.97,1) 
 
Miller et al, 2002 
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Figure 5 - Scenario tree for CWD surveillance system in wild mule and 
white-tailed deer  
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Figure  6 - CWD mean surveillance system sensitivity results (1997-2006) 
incorporating both SSc_3D and SSc_hunter surveillance components. 
Scenario 1: Surveillance sensitivity in detecting CWD if one WMZ is infected at 
1% prevalence within the region (P*H 0.04; P*U 0.01); Scenario 2: Surveillance 
sensitivity in detecting CWD if two WMZs are infected at 1% prevalence within 
these region (P*H 0.08; P*U 0.01); Scenario 3: Surveillance sensitivity in detecting 
CWD if one WMZ is infected at 2% prevalence within the region (P*H 0.04; P*U 
0.02); Scenario 4: Surveillance sensitivity in detecting CWD if two WMZs are 
infected  at 2% prevalence within the region (P*H 0.08; P*U 0.02); Scenario 5: 
Surveillance sensitivity in detecting CWD if one WMZ is infected at 5% 
prevalence within the region (P*H 0.04; P*U 0.05); Scenario 6: Surveillance 
sensitivity in detecting CWD if two WMZs are infected at 5% prevalence within 
the region (P*H 0.08; P*U 0.05). 
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 101 
Table 5 - CWD mean (95%CL) surveillance system sensitivity results (1997-
2006) incorporating both SSc_3D and SSc_hunter surveillance components 
Scenario 1: Surveillance sensitivity in detecting CWD if one WMZ is infected at 
1% prevalence within the region (P*H 0.04; P*U 0.01); Scenario 2: Surveillance 
sensitivity in detecting CWD if two WMZs are infected at 1% prevalence within 
the region (P*H 0.08; P*U 0.01); Scenario 3: Surveillance sensitivity in detecting 
CWD if one WMZ is infected at 2% prevalence within the region (P*H 0.04; P*U 
0.02); Scenario 4: Surveillance sensitivity in detecting CWD if two WMZs are 
infected  at 2% prevalence within the region (P*H 0.08; P*U 0.02); Scenario 5: 
Surveillance sensitivity in detecting CWD if one WMZ is infected at 5% 
prevalence within the region (P*H 0.04; P*U 0.05); Scenario 6: Surveillance 
sensitivity in detecting CWD if two WMZs are infected at 5% prevalence within 
the region (P*H 0.08; P*U 0.05). 
 
 
Scenario 1: 
P*H 0.04; 
P*U 0.01 
Scenario 2: 
P*H 0.08;  
P*U 0.01 
Scenario 3: 
P*H 0.04; 
P*U 0.02 
Scenario 4: 
P*H 0.08;  
P*U 0.02 
Scenario 5: 
P*H 0.04; 
P*U 0.05 
Scenario 5: 
P*H 0.08; 
P*U 0.05 
Year 
Mean 
(95% CL) 
Mean 
(95% CL) 
Mean 
(95% CL) 
Mean 
(95% CL) 
Mean 
(95% CL) 
Mean 
(95% CL) 
1997 
0.030 
(0.021;0.041) 
0.060 
(0.041;0.081) 
0.052 
(0.038;0.067) 
0.106 
(0.078;0.136) 
0.107 
(0.087;0.129) 
0.204 
(0.167;0.244) 
1998 
0.004 
(0.003;0.005) 
0.009 
(0.007;0.010) 
0.008  
(0.006;0.010) 
0.017 
(0.013;0.021) 
0.020 
(0.016;0.025) 
0.040 
(0.032;0.49) 
1999 
0.013 
(0.011;0.017) 
0.027 
(0.021;0.034) 
0.026  
(0.020;0.032) 
0.053 
(0.042;0.066) 
0.064 
(0.052;0.081) 
0.124 
(0.101;0.155) 
2000 
0.098 
(0.076;0.119) 
0.186 
(0.148;0.225) 
0.172 
(0.137;0.207) 
0.326 
(0.266;0.385) 
0.353 
(0.295;0.407) 
0.583 
(0.507;0.654) 
2001 
0.227 
(0.190;0.264) 
0.404 
(0.345;0.462) 
0.347 
(0.301;0.392) 
0.591 
(0.530;0.650) 
0.543  
(0.503;0.585) 
0.794 
(0.758;0.835) 
2002 
0.215 
(0.179;0.250) 
0.385 
(0.327;0.440) 
0.328 
(0.284;0.369) 
0.565 
(0.504;0.621) 
0.508 
(0.470;0.544) 
0.760 
(0.725;0.797) 
2003 
0.173 
(0.142;0.202) 
0.316 
(0.265;0.366) 
0.273 
(0.233;0.311) 
0.487 
(0.426;0.544) 
0.456 
(0.414;0.496) 
0.707 
(0.661;0.752) 
2004 
0.022 
(0.014;0.032) 
0.044  
(0.028;0.063) 
0.042 
(0.027;0.060) 
0.087 
(0.055;0.124) 
0.108 
(0.069;0154) 
0.210 
(0.135;0.300) 
2005 
0.065 
(0.051;0.083) 
0.127  
(0.099;0.159) 
0.120 
(0.094;0.150) 
0.234 
(0.186;0.289) 
0.269 
(0.217;0.330) 
0.469 
(0.390;0.558) 
2006 
0.047 
(0.036;0.057) 
0.092 
(0.072;0.112) 
0.085 
(0.067;0.103) 
0.169 
(0.135;0.204) 
0.189 
(0.154;0.223) 
0.343 
(0.285;0.399) 
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Figure 7 – Mean probability of freedom of CWD from 1997-2006 in Wildlife 
Management Zones (WMZs) 1, 15-18, 20, 21, 31-42, 48, 49, 56-59, estimated 
from surveillance (SSc_3D and SSc_hunter) 
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Table 6 – Mean (95%CL) probability of CWD freedom 1997-2006 in Wildlife 
Management Zones (WMZs) 1, 15-18, 20, 21, 31-42, 48, 49, 56-59, estimated 
from surveillance (SSc_3D and SSc_hunter) 
 
 
P*H 0.04; 
P*U 0.01 
pIntro 0.1 
P*H 0.04;  
P*U 0.01 
pIntro 0.01 
P*H 0.08; 
P*U 0.05 
pIntro 0.1 
P*H 0.08; 
P*U 0.05 
pIntro 0.01 
Year 
Mean 
(95% CL) 
Mean 
(95% CL) 
Mean 
(95% CL) 
Mean 
(95% CL) 
1997 
0.682 
(0.680-0.685) 
0.682 
(0.680-0.685) 
0.724 
(714-733) 
0.724 
(0.714-0.734) 
1998 
0.615 
(0.613-0.617) 
0.683 
(0.680-0.685) 
0.661 
(0.652-0.671) 
0.731 
(0.722-0.742) 
1999 
0.557 
(0.555-0.560) 
0.685 
(0.682-0.688) 
0.626 
(0.612-0.643) 
0.756 
(0.742-0.772) 
2000 
0.527 
(0.521-0.535) 
0.706 
(0.700-0.713) 
0.757 
(0.719-0.796) 
0.881  
(0.878-0.905) 
2001 
0.539 
(0.521-0.558) 
0.756 
(0.742-0.771) 
0.911 
(0.883-0.938) 
0.971 
(0.961-0.983) 
2002 
0.545 
(0.518-0.572) 
0.797 
(0.777-0.816) 
0.947 
(0.934-0.964) 
0.990 
(0.989-0.996) 
2003 
0.538 
(0.505-0.571) 
0.825 
(0.802-0.847) 
0.948 
(0.940-0.963) 
0.995 
(0.996-0.999) 
2004 
0.490 
(0.459-0.521) 
0.827 
(0.804-0.850) 
0.880 
(0.866-0.902) 
0.994 
(0.996-0.998) 
2005 
0.458 
(0.426-0.490) 
0.836 
(0.812-0.860) 
0.876 
(0.854-0.907) 
0.995 
(0.997-0.999) 
2006 
0.424 
(0.392-0.456) 
0.841 
().816-0.866) 
0.848 
(0.824-0.879) 
0.995 
(0.997-0.999) 
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Table 7 - Mean (minimum; maximum) of SSc_3D and SSc_hunter and 
sensitivity ratio using 6 different scenarios. Scenario 1: Surveillance 
sensitivity in detecting CWD if one WMZ is infected at 1% prevalence within the 
zone; Scenario 2: Surveillance sensitivity in detecting CWD if two WMZs are 
infected at 1% prevalence within these zones; Scenario 3: Surveillance sensitivity 
in detecting CWD if one WMZ is infected at 2% prevalence within the zone; 
Scenario 4: Surveillance sensitivity in detecting CWD if two WMZs are infected  
at 2% prevalence within these zones; Scenario 5: Surveillance sensitivity in 
detecting CWD if one WMZ is infected at 5% prevalence within the zone; 
Scenario 6: Surveillance sensitivity in detecting CWD if two WMZs are infected at 
5% prevalence within these zones; 
 
Scenario Design prevalence SSc_3D SSc_hunter 
Sensitivity 
ratio 
1 P*H. 04*P*U.01 
0.441  
(0.347; 0.535) 
0.035  
(0.028; 0.043) 
12.537 
 
2 P*H.08*P*U.01 
0.664  
(0.547; 0.770) 
0.069  
(0.054; 0.084) 
9.606 
 
3 P*H.04*P*U.02 
0.572 
 (0.491; 0.637) 
0.068  
(0.054; 0.083) 
8.381 
 
4 P*H.08*P*U.02 
0.818  
(0.747; 0.874) 
0.132  
(0.105; 0.159) 
6.199 
 
5 P*H.04*P*U.05 
0.657 
 (0.647; 0.727) 
0.157  
(0.127; 0.187) 
4.183 
 
6 P*H.08*P*U.05 
0.883  
(0.881; 0.931) 
0.290  
(0.238; 0.340) 
3.048 
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6. CONCLUSION 
 
With demands for wildlife surveillance information increasing and diversifying, 
laboratory submission-based passive surveillance systems can play an 
increasingly important role in disease discovery and monitoring. Although this is 
an overall biased survey with targeting of the high risk “3D” (diseased, dead, 
dying) subset of the population, it can be an effective approach to detecting new 
diseases at low prevalence, as the likelihood of finding a disease in this 
population is increased. The term ‘passive’ is misleading, in that it implies that 
little work is required to maintain such a surveillance system. In fact the opposite 
is true; maintaining financial support and vigilance can be very difficult and 
expensive. In Saskatchewan, spatial, temporal and demographic submission 
patterns were variable and heavily dependent on specific, intermittent research 
projects. Although these projects were very valuable in providing resources that 
otherwise would not have been available for wildlife disease surveillance, they 
ultimately affected the surveillance outcomes. If 3D surveillance is to be used as 
an effective surveillance system for wildlife diseases, work to improve this system 
should include improving submission rates across all regions and acquiring better 
quality information. It follows that more consistent funding of surveillance of 
wildlife populations would dramatically improve this system. 
 
Surveillance for chronic wasting disease in wild deer in Saskatchewan has 
proved to be very challenging due to factors relating to the disease itself but also 
due to a poor understanding of population structures, the lack of accurate 
denominator data and to limited resources, a challenge faced by most wildlife 
authorities.  With these challenges in mind, regular, systematic surveillance 
evaluations are essential to ensure that surveillance objectives are being met 
efficiently and effectively. This can be achieved through either qualitative or 
quantitative reviews. Qualitative reviews may be more appropriate in many 
situations where there are fewer data, as much insight can be gained simply 
through the systematic review process of clearly stating objectives, defining 
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priorities, and measuring whether objectives are being met. The recent 
development of methods using quantitative analysis, as was demonstrated in this 
manuscript, is an exciting new option for evaluating surveillance systems. 
Although these methodologies were developed primarily for providing evidence 
of disease freedom in trade of domestic animals and require abundant, good 
quality data, this methodology can be very valuable in wildlife situations provided 
adequate data is available. This methodology is also valuable in estimating 
surveillance system sensitivity and quantifying the gain in sensitivity achieved 
through targeted testing. Using this methodology to model different surveillance 
scenarios also helped to clearly demonstrate where more data were required for 
more robust modeling.   
The establishment of the hunter-harvest surveillance program has been critical in 
understanding the incursion of CWD in wild populations in Saskatchewan. It has 
helped to obtain estimates of prevalence in regions where CWD has been 
detected and to monitor the impact of disease control efforts. Large numbers of 
samples have been tested in CWD-positive areas as part of the population 
reduction initiatives. The trade-off has been that in many areas with current 
‘negative’ status, few samples have been submitted, providing little evidence that 
the disease is not present. Further evaluation of the level of surveillance required 
in CWD-positive areas should occur to prevent oversampling in these areas, and 
to save more resources for disease detection in ‘CWD-negative’ areas. 
In theory, hunter-harvest surveillance is less efficient at detecting disease in 
areas of low prevalence than targeting ‘3D’ animals. Clinically ill animals, 
especially CWD suspects, have a much higher probability of being infected. 
Although this is true in theory, there are many challenges that impair the 
sensitivity of ‘3D’ surveillance that must be overcome for it to be effective. The 
current clinical surveillance component is not sufficient to fill in the ‘gaps’ and the 
primary reason for poor performance by this component has been a very low 
submission rate. Enhancing this system in areas where the disease has not been 
detected would improve sensitivity. This will likely require additional resources for 
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education and awareness campaigns and for front-line staff, but given the 
importance of managing this disease, would be money well spent.  
The overall sensitivity of a surveillance system and confidence of disease 
freedom are highly dependent on detection prevalence and the ongoing risk of 
disease introduction. The lower the prevalence, the higher the surveillance 
intensity required. Additionally, ongoing risk or disease introduction must be 
continually assessed in order to adjust the value of previous testing. With these 
two factors in mind, a detection goal of 0.5-1% prevalence is an ambitious 
surveillance goal, especially in areas where the risk of disease introduction is 
high. Further refinement of CWD surveillance at the regional level, based on the 
surveillance goals (estimating prevalence and monitoring trends vs. early disease 
detection) would help to meet overall surveillance objectives. A point system, 
similar to that developed by the OIE for BSE surveillance, could be developed, 
making it more user-friendly and comprehensible for conservation officers and 
managers to meet local surveillance system goals.  
 
Based on this analysis, surveillance in the eastern part of Saskatchewan is not 
adequate to detect CWD at 0.5-1% prevalence. Having said that, this area has 
not been a focus of surveillance and even with the limited surveillance that has 
been done, it can be concluded that if the risk of disease introduction was very 
low, the prevalence is not 5% or higher. The use of more targeted surveillance 
strategies should be further explored to help better meet surveillance objectives.  
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